CORVE L CORPORATION / 2015 ANNUAL REP ORT an d FORM 10-K
TEC HNOLOGY
INTELLIGENCE
HUMAN TOUCH
SHAREHOLDERS’ LETTER
2015 was a transition year for CorVel. Our expansion in both workers’ compensation claims management and also in
the broader healthcare markets for medical review, continued. Our investments in these efforts outpaced our sales,
not entirely unexpected in most expansions. We continued to add to the scope of our medical management services
during the onset of an episode of care, including new online access to nurses as well as telemedicine services.
The national implementation of the Affordable Care Act, particularly in the health markets, introduced a period of
uncertainty for our customers and for CorVel. Accommodating the Act has diluted insurers’ ability to implement other
changes in their approach to cost containment. Various segments of the health market remain attractive to CorVel,
even in the face of several years of expected evolution.
Our product development is in a period of particularly important goals: converting claims processing from an
administrative activity to one of care management, interfacing CorVel’s systems electronically with patients,
providers and payors, and achieving new improved outcomes. These are complex projects; however, the continuous
improvement effort maintains focus on each, every year.
Increasing deployment of technology allows us to apply resources to manage the initial phases of a new episode of
care, rather than have those resources be absorbed by the traditional effort required for necessary administrative
activities. CorVel can now cost effectively provide both nursing support and telephonically available physician access
for patients immediately following a disabling event. These new processes greatly accelerate patient assessment,
triaging and care, improving return to work outcomes.
The complete suite of services involved in administering workers’ compensation claims can be far more effectively
integrated with one another. CorVel introduced enhancements in CareMC, our interactive claims portal, to incorporate
the information in traditionally disparate services in real time. Just as manufacturers once introduced automation
in manufacturing, we expect technology to meaningfully restructure the market for healthcare management. The
strategic initiatives supporting service integration continued throughout the year, with more capabilities planned in
the current year.
CorVel completed the first version of its mobile patient application. Although smartphones are now ubiquitous, we
expect the next five years to see more robust capabilities to bring conveniences to many markets, including healthcare.
The implications of expanded use of mobile technologies are far reaching. Interacting with, and serving healthcare
professionals is an aspect of claims management where CorVel has unique capabilities. The systems supporting
our Preferred Provider Networks (PPOs) are being strengthened to allow for better presentation of healthcare
professional capabilities and to better link the separate stages of an episode of care. Improving the support to
providers also helps us in our efforts to increase the breadth and depth of our network.
The combined effect of these various projects is to shorten the lag times inherent in an episode of care, improving
the timeliness and appropriateness of return to work. There is much more to do and we see no end to this effort. The
foundations we continue to build position CorVel very well for the inevitable changes coming in healthcare.
Although technology is a key to building the value of our Company, as always, the people of CorVel continue to
persevere through these stages of development. The broad reach of our branch network positions our staff in the
same communities as our clients and patients. Their energy and entrepreneurial spirit repeatedly surface new ideas
and solutions, keeping the queue of new projects full. We thank our invested clients and our determined associates
for providing the energy which fuels our journey. There is no equal to the value these relationships create.
Gordon Clemons
Chairman and CEO
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO SECTIONS 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended March 31, 2015
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the transition period from to
Commission File Number 0-19291
CorVel Corporation
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
2010 Main Street, Suite 600,
Irvine, California
(Address of principal executive offices)
33-0282651
(I.R.S. Employer
Identification Number)
92614
(Zip Code)
Registrant’s telephone number, including area code:
(949) 851-1473
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:
Common Stock
Name of each exchange on which registered:
The NASDAQ Global Select Market, LLC
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act Yes No
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act Yes No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90
days. Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted
and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit
and post such files). Yes No
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s
knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of
“large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Non-accelerated filer
Accelerated filer
Smaller reporting company
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last
sold, or the average bid and asked price of such common equity, as of the last business day of the Registrant’s most recently completed second fiscal quarter:
As of September 30, 2014, the aggregate market value of the Registrant’s voting and non-voting common equity held by non-affiliates of the Registrant was approximately
$386,692,000 based on the closing price per share of $34.05 for the Registrant’s common stock as reported on the Nasdaq Global Select Market on such date multiplied by
11,356,597 shares (total outstanding shares of 20,727,355 less 9,370,758 shares held by affiliates) of the Registrant’s common stock which were outstanding on such date. For the
purposes of the foregoing calculation only, all of the Registrant’s directors, executive officers and persons known to the Registrant to hold ten percent or greater of the Registrant’s
outstanding common stock have been excluded in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive
determination for other purposes.
Indicate the number of shares outstanding of each of the Registrant’s classes of common stock, as of the latest practicable date: As of June 5, 2015, there were 20,091,126
shares of the Registrant’s common stock, par value $0.0001 per share, outstanding.
Information required by Items 10 through 14 of Part III of this Form 10-K, to the extent not set forth herein, is incorporated herein by reference to portions of the Registrant’s
definitive proxy statement for the Registrant’s 2015 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission not later than 120 days
after the end of the fiscal year ended March 31, 2015. Except with respect to the information specifically incorporated by reference in this Form 10-K, the Registrant’s definitive
proxy statement is not deemed to be filed as a part of this Form 10-K.
DOCUMENTS INCORPORATED BY REFERENCE
CORVEL CORPORATION
2015 FORM 10-K ANNUAL REPORT
TABLE OF CONTENTS
Item 1.
Business ......................................................................................................................................................................................................................
2
Item 1A.
Risk Factors ................................................................................................................................................................................................................
11
Item 1B.
Unresolved Staff Comments .......................................................................................................................................................................................
17
PART I
Page
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
Item 7.
Properties ....................................................................................................................................................................................................................
17
Legal Proceedings ......................................................................................................................................................................................................
17
Mine Safety Disclosures .............................................................................................................................................................................................
17
PART II
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities .........................................................................................................................................................................................................
18
Selected Financial Data ..............................................................................................................................................................................................
19
Management’s Discussion and Analysis of Financial Condition and Results of Operations .....................................................................................
19
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk ....................................................................................................................................
20
Item 8.
Item 9.
Financial Statements and Supplementary Data ..........................................................................................................................................................
20
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure .....................................................................................
20
Item 9A.
Controls and Procedures .............................................................................................................................................................................................
20
Item 9B.
Other Information .......................................................................................................................................................................................................
21
PART III
Item 10.
Directors, Executive Officers and Corporate Governance .........................................................................................................................................
22
Item 11.
Executive Compensation ............................................................................................................................................................................................
22
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters ..........................................................................
22
Item 13.
Certain Relationships and Related Transactions, and Director Independence............................................................................................................
22
Item 14.
Principal Accounting Fees and Services .....................................................................................................................................................................
22
Item 15.
Exhibits, Financial Statement Schedules ....................................................................................................................................................................
23
Signatures ...................................................................................................................................................................................................................
29
PART IV
In this report, the terms “CorVel”, “Company”, “we”, “us”, and “our” refer to CorVel Corporation and its subsidiaries.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, and the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), including, but not limited to, the statements about our
plans, strategies and prospects under the headings “Business” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” and elsewhere in this report. Words such as “expects”, “anticipates”, “intends”,
“plans”, “predicts”, “believes”, “seeks”, “estimates”, “potential”, “continue”, “strive”, “ongoing”, “may”, “will”, “would”,
“could”, and “should”, and variations of these words or similar expressions are intended to identify forward-looking
statements. These forward-looking statements are based on management’s current expectations, estimates and projections
about our industry, management’s beliefs, and certain assumptions made by management, and we can give no assurance that
we will achieve our plans, intentions or expectations. Certain important factors could cause actual results to differ materially
from the forward-looking statements we make in this report. Representative examples of these factors
include (without limitation):
• General industry and economic conditions, including a decreasing number of national claims due to decreasing
number of injured workers;
• Cost of capital and capital requirements;
• Competition from other managed care companies;
• The Company’s ability to renew and/or maintain contracts with its customers on favorable terms or at all;
• The ability to expand certain areas of the Company’s business;
• Possible litigation and legal liability in the course of operations, and the Company’s ability to settle or otherwise
resolve such litigation;
• The ability of the Company to produce market-competitive software;
Increases in operating expenses, including employee wages, benefits and medical inflation;
•
• Changes in regulations affecting the workers’ compensation, insurance and healthcare industries in general;
• The ability to attract and retain key personnel;
•
Shifts in customer demands; and
• The availability of financing in the amounts, at the times, and on the terms necessary to support the Company’s
future business.
The section entitled “Risk Factors” set forth in this report discusses these and other important risk factors that may
affect our business, results of operations and financial condition. The factors listed above and the factors described under the
heading “Risk Factors” and similar discussions in our other filings with the Securities and Exchange Commission are not
necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our
forward-looking statements. Other unknown or unpredictable factors also could have material adverse effects on our future
results. Investors should consider these factors before deciding to make or maintain an investment in our securities. The
forward-looking statements included in this annual report on Form 10-K are based on information available to us as of the
date of this annual report. We expressly disclaim any intent or obligation to update any forward-looking statements to reflect
subsequent events or circumstances.
1
Business.
Item 1.
INTRODUCTION
PART I
CorVel is a national provider of workers’ compensation solutions for employers, third party administrators, insurance
companies, and government agencies seeking to control costs and promote positive outcomes. The Company applies
technology, intelligence, and a human touch to the challenges of risk management so that their clients can intervene early and
often while being connected to the critical intelligence they need to proactively manage risk. CorVel specializes in applying
advanced communication and information technology to improve healthcare management for workers’ compensation, group
health, auto and liability claims management. With a technology platform at its core, the Company’s connected solution is
delivered by a national team of associates who are committed to helping clients deliver programs that meet their
organization’s performance goals.
The Company’s services include claims management, bill review, preferred provider networks, utilization
management, case management, pharmacy services, directed care and Medicare services. CorVel offers its services as a
bundled solution (i.e. claims management), as a standalone service, or as add-on services to existing customers. Customers of
the Company that do not purchase a bundled solution generally use another provider, use an in-house solution, or choose not
to utilize such a service to manage their workers’ compensation costs. When customers purchase several products from
CorVel, the pricing of the products sold is generally the same as if the product were sold on an individual basis. Bundled
products are generally delivered in the same accounting period.
The Company was incorporated in Delaware in 1987, and its principal executive offices are located at 2010 Main
Street, Suite 600, Irvine, California, 92614. The Company’s telephone number is 949-851-1473.
INDUSTRY OVERVIEW
Workers’ compensation is a federally mandated, state-legislated, insurance program that requires employers to fund
medical expenses, lost wages and other costs resulting from work-related injuries and illnesses. Workers’ compensation
benefits and arrangements vary extensively on a state-by-state basis and are often highly complex. State statutes and court
decisions control many aspects of the compensation process, including claims handling, impairment or disability evaluation,
dispute settlement, benefit amount guidelines and cost-control strategies.
In addition to the compensation process, cost containment and claims management continue to be significant employer
concerns and many look to managed care vendors and third party administrators for cost savings solutions. The Company
believes that cost drivers in workers’ compensation include: implementing effective return to work and transitional duty
programs, coordinating medical care, medical cost management, recognizing fraud and abuse, and improving
communications with injured workers. CorVel provides solutions using a holistic approach to cost containment and by
looking at a complete savings solution. Often one of the biggest cost drivers is not recognizing a complex claim at the onset
of an injury often resulting in claims being open longer and resulting in a delayed return to work. CorVel uses an integrated
claims model that controls claims costs by advocating medical management at the onset of the injury to decrease
administrative costs and to shorten the length of the disability.
Some states have adopted legislation for managed care organizations (MCO) in an effort to allow employers to control
their worker’s compensation costs. A managed care plan is organized to serve the medical needs of injured workers in an
efficient and cost-effective manner by managing the delivery of medical services through appropriate health care
professionals. CorVel is registered wherever legislation mandates, where it is beneficial for the Company to obtain a license,
or where the MCO is an effective utilized mandate. Since MCO legislation varies by state, CorVel’s state offerings vary as
well. CorVel continually evaluates new legislation to ensure it is in compliance and can offer services to its customers
and prospects.
2
FISCAL 2015 DEVELOPMENTS
Company Stock Repurchase Program
During fiscal 2015, the Company continued to repurchase shares of its common stock under a plan originally approved
by the Company’s Board of Directors in 1996. In August 2013, the Company’s Board of Directors increased the number of
shares authorized to be repurchased over the life of the plan by 2,000,000 shares to 34,000,000 shares. During fiscal 2015, the
Company spent $31.8 million to repurchase 845,014 shares of its common stock. Since commencing this program in the fall
of 1996, the Company has repurchased 32,992,488 shares of its common stock through March 31, 2015, at a cost of $360
million. These repurchases were funded primarily from the Company’s operating cash flows.
BUSINESS — SERVICES
The Company offers services in two general categories, network solutions and patient management, to assist its
customers in managing the increasing medical costs of workers’ compensation, group health and auto insurance, and
monitoring the quality of care provided to claimants. CorVel reduces claims costs by advocating medical management at the
onset of an injury to decrease administrative costs and to shorten the length of the disability. These solutions offer
personalized treatment programs that use precise treatment protocols to advocate timely, quality care for injured workers.
Network Solutions
CorVel offers a complete medical savings solution for all in-network and out-of-network medical bills including PPO
management, specialty networks, medical bill repricing, true line item review, expert fee negotiations, professional nurse
review, automated adjudication and electronic reimbursement. Each feature focuses on increasing processing efficiencies and
maximizing savings opportunities.
Bill Review
Many states have adopted fee schedules, which regulate the maximum allowable fees payable under workers’
compensation, for procedures performed by a variety of health treatment providers. Developed in 1989, CorVel’s proprietary
bill review and claims management technology automates the review process to provide customers with a faster turnaround
time, more efficient bill review and a higher total savings. CorVel’s artificial intelligence engine includes over sixty million
individual rules, which creates a comprehensive review process that is more efficient than traditional manual bill
review processes.
Payors are able to review and approve bills online as well as access savings reports through an online portal, CareMC.
The process is paperless, through scanning and electronic data interface (“EDI”), while proving to be cost effective and
efficient. CorVel’s solutions are fully customizable and can be tailored to meet unique payor requirements.
Bill Review Services include:
•
•
•
•
•
•
•
Coding review and re-bundling
Reasonable and customary review
Fee schedule analysis
Out-of-network bill review
Pharmacy review
PPO management
Repricing
PPO Management
PPOs are groups of hospitals, physicians and other healthcare providers that offer services at pre-negotiated rates to
employee groups. The Company believes that PPO networks offer the employer an additional means of managing healthcare
costs by reducing the per-unit price of medical services provided to employees. CorVel began offering a proprietary national
PPO network in 1992 and today it is comprised of over 750,000 board-certified providers. The Company provides the
convenience of a PPO Provider look-up mobile application for use with iPhone, iPad and Android. The application is
available to the public and makes it convenient to locate a provider in the CorVel network. Users can search providers based
on quality, range of services and location.
3
CorVel has a long-term strategy of network development, providing comprehensive networks to our customers and
customization of networks to meet the specific needs of our customers. The Company believes that the combination of its
national PPO strength and presence and the local PPO developers’ commitment and community involvement enables CorVel
to build, support and strengthen its PPO in size, quality, depth of discount, and commitment to service.
The Company has a team of national, regional and local personnel supporting the CorVel network. This team of PPO
developers are responsible for local recruitment, contract negotiations, credentialing and re-credentialing of providers, and
working with customers to develop customer specific provider networks. Each bill review operation has provider relations
support staff to address provider grievances and other billing issues.
Providers are selected from criteria based on quality, range of services, price and location. Each provider is thoroughly
evaluated and credentialed, then re-credentialed every three years. Through this extensive evaluation process, we are able to
provide significant hospital, physician and ancillary medical savings, while maintaining high quality care. Provider network
services include a national network for all medical coverages, board-certified physicians, provider credentialing, patient
channeling, online PPO look-up, printable directories and driving directions, and Managed Care Organizations (MCO).
CERiSSM
CERiS, CorVel’s enhanced bill review program, allows claim payors to adjust individual line item charges on all bills
to reasonable and customary levels while removing all error and billing discrepancies with professional review. The enhanced
bill review program scrutinizes each hospital line description and charge as a separate and distinct claim for reimbursement.
CorVel’s proprietary Universal Chargemaster defines each code and description, enabling its registered nurses to identify
errors, duplicate charges, re-bundle exploded charges, correct quantity discrepancies and remove unused supplies.
Professional Review
CorVel’s services offer a complete audit and validation of facility bill accuracy. This solution also includes review of
in-network facility bills. The Company’s experienced nurse auditors have clinical backgrounds in all areas of medicine,
medical billing and coding to ensure an accurate, consistent and thorough review. If a bill is identified for professional
review, the bill image and its associated medical reports are routed within the system to an experienced medical nurse for
review and auditing.
Provider Reimbursement
One of the interfaces of CorVel’s bill review service is the automated issuance of provider reimbursements. CorVel’s
provider reimbursement service allows the ability to determine dollars spent and bills reviewed and to assist in setting
reserves through charts available online. Through the bill review system, CorVel has the capability to provide check writing
or provider reimbursement services for its customers. The provider payment check can be added to the bill analysis to
produce one combined document.
Pharmacy Services
CorVel provides patients with a full-feature pharmacy program that offers formulary management, discounted
prescriptions, drug interaction monitoring, utilization management and eligibility confirmation. Our pharmacy network of
nationally recognized pharmacies provides savings off the retail price of prescriptions associated with a workers’
compensation claim. The Company’s pharmacy services program includes preferred access to a national pharmacy network,
streamlined processing for pharmacies at point of sale, first fill and next fill programs, mail order and 90-day retail options,
out-of-network management, medication review services and clinical modeling.
Directed Care Services
CorVel offers a national directed care network that provides access to specialty medical services which may be
required to support an injured worker’s medical treatment plan. CorVel has contracted with medical imaging, physical
therapy, diagnostics and ancillary service networks to offer convenient access, timely appointments and preferred rates for
these services. The Company manages the entire coordination of care from appointment scheduling through reimbursement,
working to achieve timely recovery and increased savings. The Company has directed care networks for CT and bone scans,
diagnostic imaging, physical and occupational therapy, independent medical evaluations, durable medical equipment and
transportation and translation.
4
Medicare Solutions
The Company offers solutions to help manage the requirements mandated by the Centers for Medicare and Medicaid
Services (CMS). Services include Medicare Set Asides and Agent Reporting Services to help employers comply with new
CMS reporting legislation. As an assigned agent, CorVel can provide services for Responsible Reporting Entities (RRE) such
as insurers and employers. As an experienced information-processing provider, CorVel is able to electronically submit files
to the CMS in compliance with timelines and reporting requirements.
Clearinghouse Services
CorVel’s proprietary medical review software and claims management technology interfaces with multiple
clearinghouses. The Company’s clearinghouse services provide for medical review, conversion of electronic forms to
appropriate payment formats, seamless submittal of bills for payments and rules engines used to help ensure
jurisdictional compliance.
Patient Management
CorVel offers a unique approach to claims administration and patient management. This integrated service model
controls claims by advocating medical management at the onset of the injury to decrease administrative costs and to shorten
the length of the disability. This automated solution offers a personalized treatment program for each injured worker, using
precise treatment protocols to meet the changing needs of patients on a frequent basis. The Company offers these services on
a stand-alone basis or as an integrated component of its medical cost containment services.
Claims Management
CorVel has been a third party administrator (“TPA”) offering claims management services since January 2007. The
Company serves customers in the self-insured or commercially-insured markets. Incidents and injuries are reported through a
variety of intake methods that include a 24/7 nurse triage call center, website, mobile applications, toll-free call centers and
traditional methods of paper and fax reporting. They are immediately processed by CorVel’s proprietary rules engine, which
provides alerts and recommendations throughout the life of a claim. This technology instantly assigns an expert claims
professional, while simultaneously determining if a claim requires any immediate attention for triage.
Through this service, the Company serves clients in the self-insured or commercially-insured market through
alternative loss funding methods, and provides them with a complete range of services, including claims administration, case
management, and medical bill review. In addition to the field investigation and evaluation of claims, the Company also may
provide initial loss reporting services for claims, loss mitigation services such as medical bill review and vocational
rehabilitation, administration of trust funds established to pay claims and risk management information services.
Some of the features of claims management services include: automated first notice of loss, three-point contact within
24 hours, prompt claims investigations, detailed diary notes for each step of the claim, graphical dashboards and claim
history scorecards, and litigation management and expert testimony.
Case Management
CorVel’s case management and utilization review services address all aspects of disability management and recovery
including utilization review (pre-certification, concurrent review and discharge planning), early intervention, telephonic, field
and catastrophic case management as well as vocational rehabilitation.
The medical management components of CorVel’s program focus on medical intervention, management and
appropriateness. In these cases, the Company’s case managers confer with the attending physician, other providers, the
patient and the patient’s family to identify the appropriate rehabilitative treatment and most cost-effective healthcare
alternatives. The program is designed to offer the injured party prompt access to appropriate medical providers who will
provide quality cost-effective medical care. Case managers may coordinate the services or care required and may arrange for
special pricing of the required services.
5
The Telephonic Case Manager (TCM) continues to impact the direction of the case, focusing on early return to work,
maximum medical improvement (MMI) and appropriate duration of disability. Facilitation of appropriate treatment, assertive
negotiation with medical providers and directing the care of the injured worker continues to be the Case Manager’s role until
the closure criteria is met. Utilization review of provider treatment remains ongoing until discharge from treatment.
In the event that a claim may require an onsite referral, a Field Case Manager (FCM) will be assigned to the claim.
Cases can be referred to CorVel based on geographic location and injury type to the most appropriate FCM. Specialized case
management services include catastrophic management, life care planning, and vocational rehabilitation services. All FCMs
have iPads that provide access to the Company’s proprietary mobile applications that provide instant access to detailed case
information and the ability to enter case notes. An additional feature of our iPad applications is the ability to electronically
approve and email signed case management forms and documentation.
24/7 Nurse Triage
Injured workers can call at the time of injury or incident and speak with a registered nurse who specializes in
occupational injuries. An assessment is immediately made to recommend self-care, or referral for further medical care if
needed. CorVel is able to provide quick and accurate care intervention, often preventing a minor injury from becoming an
expensive claim. The 24/7 nurse triage services provide channeling to a preferred network of providers, allows employer
access to online case information, comprehensive incident gathering, and healthcare advocacy for injured workers.
Utilization Management
Utilization Management programs review proposed care to determine appropriateness, frequency, duration and setting.
These programs utilize experienced registered nurses, proprietary medical treatment protocols and systems technology to
avoid unnecessary treatments and associated costs. Processes in Utilization Management include: injury review, diagnosis
and treatment planning; contacting and negotiating provider treatment requirements; certifying appropriateness of treatment
parameters, and responding to provider requests for additional treatment. Utilization management services include:
prospective review, retrospective review, concurrent review, professional nurse review, second opinion, peer review,
precertifications and independent medical evaluation.
Vocational Rehabilitation
CorVel’s Vocational Rehabilitation program is designed for injured workers needing assistance returning to work or
retaining employment. This comprehensive suite of services helps employees who are unable to perform previous work
functions and who face the possibility of joining the open labor market to seek re-employment. These services are available
unbundled, on an integrated basis as dictated by the requirement of each case and client preference, or by individual statutory
requirements. Vocational rehabilitation services include ergonomic assessments, rehabilitation plans, transferable skills
analysis, labor market services, job seeking skills, resumé development, job analysis and development, job placement, career
counseling and expert testimony.
Life Care Planning
Life Care Planning is used to project long-term future needs, services and related costs associated with a catastrophic
injury. CorVel’s Life Care Plans summarize extensive amounts of medical data and compile it into a comprehensive report
for future care requirements, aiding improved outcomes and timely resolution of claims. The Life Care Plans also provide
working guidelines and points of reference for the family of a disabled person. Some of the features of the Company’s Life
Care Planning services include: comprehensive documentation, projecting future care requirements, customized reporting,
certified documentation and costs specific to local areas.
Disability Management
CorVel’s disability management programs offer a continuum of services for short and long-term disability coverages
that advocate an employee’s early return to work. Disability management services include absence reporting, disability
evaluations, national preferred provider organizations, independent medical examinations, utilization review, medical case
management, return to work coordination and integrated reporting.
6
Liability Claims Management
CorVel also offers liability claims management services that can be sold as a stand-alone service or part of patient
management. The Company’s services include auto liability, general liability, product liability, personal injury, professional
liability and property damage, accidents and weather-related damage. This service includes claims management, adjusting
services, litigation management, claims subrogation, and investigations.
Auto Claims Management
Injury claims are one of the largest components of auto indemnity costs. Effective management of these claims and
their associated costs, combined with an optimal healthcare management program, helps CorVel’s customers reduce claim
costs. The Company’s auto claims services include national preferred provider organizations, medical bill review, first and
third party bill review, first notice of loss, demand packet reviews and reporting and analytics.
SYSTEMS AND TECHNOLOGY
Infrastructure and Data Center
The Company utilizes a Tier III-rated data center as its primary processing site. Redundancy is provided at many levels
in power, cooling, and computing resources, with the goal of ensuring maximum uptime and system availability for the
Company’s production systems. The Company has fully embraced server virtualization and consolidation techniques to push
the fault-tolerance of systems even further. These technologies bring increased availability, speed-to-production
and scalability.
Adoption of Imaging Technologies and Paperless Workflow
Utilizing scanning and automated data capture processes allows the Company to process incoming paper and electronic
claims documents, including medical bills, with less manual handling and which has improved the Company’s workflow
processes. This has benefited both the Company, in terms of cost-savings, and the Company’s customers, in improved
savings results. Through the Company’s internet portal, www.caremc.com, customers can review the bills as soon as they are
processed and approve a bill for payment, streamlining the customer’s own workflows and expediting the payment process.
Redundancy Center
The Company’s national data center is located near Portland, Oregon. The Company has migrated its redundancy
center from Fort Worth, Texas to Las Vegas, Nevada. The redundancy center is the Company’s backup processing site in the
event that the Portland data center suffers catastrophic loss. Currently, the Company’s data is continually replicated to Las
Vegas in near-real time, so that in the event the Portland data center is offline, the redundancy center can be activated with
current information quickly. The Las Vegas data center also hosts duplicates of the Company’s websites. The Las Vegas
systems are maintained and exercised on a continuous basis as they host demonstration and pilot environments that mirror
production, with the goal of ensuring their ongoing readiness.
CareMCSM
CareMC (www.caremc.com) has become the application platform for all of the Company’s primary service lines and
delivers immediate access to customers. CareMC offers customers direct access to the Company’s primary services. CareMC
allows for electronic communication and reporting between providers, payers, employers and patients. Features of the
website include: report an incident/injury, request for service, appointment scheduling, online bill review, claims information
management, treatment calendar, medical bill adjudication and automated provider reimbursement.
Through the CareMC Website, users can:
Request services online;
•
• Manage files throughout the life of the claim;
•
•
Receive and relay case notes from case managers; and
Integrate information from multiple claims management sources into one database.
7
The CareMC website facilitates healthcare transaction processing. Using artificial intelligence techniques, the website
provides situation alerts and event triggers, to facilitate prompt and effective decisions. Users of CareMC can quickly see
where event outliers are occurring within the claims management process. If costs exceed pre-determined thresholds or
activities fall outside expected timelines, decision-makers can be quickly notified. Large amounts of information are
consolidated and summarized to help customers focus on the critical issues.
Scanning Services
We continue to leverage our scanning technologies which include scanning, optical character recognition and
document management services. We continue to expand our existing office automation service line and all offices are selling
scanning and document management. We have added scanning operations to most of the Company’s larger offices
around the country, designating them “Capture Centers.” Our scanning service also offers a web interface
(www.onlinedocumentcenter.com) providing immediate access to documents and data called the Online Document Center
(ODC). Secure document review, approval, transaction workflow and archival storage are available at
subscription-based pricing.
Claims Processing
We continue to develop our claims system capabilities which fit well with the Company’s preference for owning and
maintaining our own software assets. Integration projects, some already completed, are underway to present more of this
claims-centric information available through the CareMC web portal. The Company’s goal is to continue to modernize user
interfaces, and to streamline the delivery of this information to our customers, giving more rapid feedback and putting real-
time information in the hands of our customers.
INDUSTRY, CUSTOMERS AND MARKETING
CorVel serves a diverse group of customers that include insurers, third party administrators, self-administered
employers, government agencies, municipalities, state funds, and numerous other industries. CorVel is able to provide
workers’ compensation services to virtually any size employer and in any state or region of the United States. No single
customer of the Company represented more than 10% of revenues in fiscal 2013, 2014, or 2015. Many claims management
decisions in workers’ compensation are the responsibility of the local claims office of national or regional insurers. The
Company’s national branch office network enables the Company to market and offer its services at both a local and national
account level. The Company is placing increasing emphasis on national account marketing. The sales and marketing
activities of the Company are conducted primarily by account executives located in key geographic areas.
COMPETITION AND MARKET CONDITIONS
The healthcare cost containment industry is competitive and is subject to economic pressures for cost savings and
legislative reforms. CorVel’s primary competitors in the workers’ compensation market include third party administrators,
managed care companies, large insurance carriers and numerous independent companies. Many of the Company’s
competitors are significantly larger and have greater financial and marketing resources than the Company. Moreover, the
Company’s customers may establish the in-house capability of performing services offered by the Company. If the Company
is unable to compete effectively, it will be difficult to add and retain customers, and the Company’s business, financial
condition and results of operations will be materially and adversely affected.
The past few years have seen acceleration in the technology world, and advancements seem to be progressing at a pace
that few, if any, have ever witnessed. The proliferation of smart phones and tablet computers allows the Company’s clients to
stay connected at any time, from anywhere. This capability provides immediate access and begins to present business
opportunities that were previously predicated on a less connected environment. The Company continues to leverage the new
wave of technology in order to connect all of the parties involved in the workers’ compensation process in ways that were
unimaginable in the past. As with general health, the workers compensation line continues to migrate to being a medical
management business, with policymakers, employers, and carriers struggling to manage and control the costs of medical care
(Source “National Council on Compensation Insurance”). The Company will continue to focus the execution of its strategy to
provide industry leading claims management and cost containment solutions to the market.
We are required to be licensed or receive regulatory approval in nearly every state and foreign jurisdiction in which we
do business. In addition, most jurisdictions require individuals who engage in claim adjusting and certain other insurance
service activities to be personally licensed. These licensing laws and regulations vary from jurisdiction to jurisdiction. In
most jurisdictions, licensing laws and regulations generally grant broad discretion to supervisory authorities to adopt and
amend regulations and to supervise regulated activities.
8
GOVERNMENT REGULATIONS
General
Managed healthcare programs for workers’ compensation are subject to various laws and regulations. Both the nature
and degree of applicable government regulation vary greatly depending upon the specific activities involved. Generally,
parties that actually provide or arrange for the provision of healthcare services, assume financial risk related to the provision
of those services or undertake direct responsibility for making payment or payment decisions for those services. These parties
are subject to a number of complex regulatory requirements that govern many aspects of their conduct and operations.
In contrast, the management and information services provided by the Company to its customers typically have not
been the subject of regulation by the federal government or the states. Since the managed healthcare field is a rapidly
expanding and changing industry and the cost of providing healthcare continues to increase, it is possible that the applicable
state and federal regulatory frameworks will expand to have a greater impact upon the conduct and operation of the
Company’s business.
Under the current workers’ compensation system, employer insurance or self-funded coverage is governed by
individual laws in each of the 50 states and by certain federal laws. The management and information services that make up
the Company’s managed care program serve markets that have developed largely in response to needs of insurers, employers
and large TPAs, and generally have not been mandated by legislation or other government action. On the other hand, the
vocational rehabilitation case management marketplace within the workers’ compensation system has been dependent upon
the laws and regulations within those states that require the availability of specified rehabilitation services for injured
workers. Similarly, the Company’s fee schedule auditing services address market needs created by certain states’ enactment
of maximum permissible fee schedules for workers’ compensation services. Changes in individual state regulation of
workers’ compensation may create a greater or lesser demand for some or all of the Company’s services or require the
Company to develop new or modified services in order to meet the needs of the marketplace and compete effectively in
that marketplace.
Medical Cost Containment Legislation
Historically, governmental strategies to contain medical costs in the workers’ compensation field have been generally
limited to legislation on a state-by-state basis. For example, many states have implemented fee schedules that list maximum
reimbursement levels for healthcare procedures. In certain states that have not authorized the use of a fee schedule, the
Company adjusts bills to the usual and customary levels authorized by the payor. Opportunities for the Company’s services
could increase if more states legislate additional cost containment strategies. Conversely, the Company would be materially
and adversely affected if states elect to reduce the extent of medical cost containment strategies available to insurance carriers
and other payors, or adopt other strategies for cost containment that would not support a demand for the Company’s services.
SHAREHOLDER RIGHTS PLAN
During fiscal 1997, the Company’s Board of Directors approved the adoption of a Shareholder Rights Plan. The
Shareholder Rights Plan provides for a dividend distribution to CorVel stockholders of one preferred stock purchase right for
each outstanding share of CorVel’s common stock under certain circumstances. In April 2002, the Board of Directors of
CorVel approved an amendment to the Shareholder Rights Plan to extend the expiration date of the rights to February 10,
2012, set the exercise price of each right at $118, and enable Fidelity Management & Research Company and its affiliates to
purchase up to 18% of the shares of common stock of the Company without triggering the stockholder rights, with the
limitations under the Shareholder Rights Plan remaining in effect for all other stockholders of the Company. In November
2008, the Company’s Board of Directors approved an amendment to the Shareholder Rights Plan to extend the expiration
date of the rights to February 10, 2022, remove the ability of Fidelity Management & Research Company and its affiliates to
purchase up to 18% of the shares of common stock of the Company without triggering the stockholder rights, substitute
Computershare Trust Company, N.A. as the rights agent and effect certain technical changes to the Shareholder Rights Plan.
The rights are designed to assure that all shareholders receive fair and equal treatment in the event of any proposed
takeover of the Company and to encourage a potential acquirer to negotiate with the Board of Directors prior to attempting a
takeover. The rights have an exercise price of $118 per right, subject to subsequent adjustment. The rights trade with the
Company’s common stock and will not be exercisable until the occurrence of certain takeover-related events.
9
Generally, the Shareholder Rights Plan provides that if a person or group acquires 15% or more of the Company’s
common stock without the approval of the Board, subject to certain exception, the holders of the rights, other than the
acquiring person or group, would, under certain circumstances, have the right to purchase additional shares of the Company’s
common stock having a market value equal to two times the then-current exercise price of the right.
In addition, if the Company is thereafter merged into another entity, or if 50% or more of the Company’s consolidated
assets or earning power are sold, then the right will entitle its holder to buy common shares of the acquiring entity having a
market value equal to two times the then-current exercise price of the right. The Company’s Board of Directors may
exchange or redeem the rights under certain conditions.
EMPLOYEES
As of March 31, 2015, CorVel had 3,548 employees, including nurses, therapists, counselors and other employees. No
employees are represented by any collective bargaining unit. Management believes the Company’s relationship with its
employees to be good.
AVAILABLE INFORMATION
Copies of our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and
amendments to those reports filed or furnished pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934,
and other filings made with the Securities and Exchange Commission, are available free of charge through our Web site
(http://www.corvel.com, under the Investor section) as soon as reasonably practicable after such reports are electronically
filed with, or furnished to, the Securities and Exchange Commission. The inclusion of our Web site address and the address
of any of our portals, such as www.caremc.com and www.onlinedocumentcenter.com, in this report does not include or
incorporate by reference into this report any information contained on, or accessible through, such Web sites.
10
Item 1A.
Risk Factors
Past financial performance is not necessarily a reliable indicator of future performance, and investors in our common
stock should not use historical performance to anticipate results or future period trends. Investing in our common stock
involves a high degree of risk. Investors should consider carefully the following risk factors, as well as the other information
in this report and our other filings with the Securities and Exchange Commission, including our consolidated financial
statements and the related notes, before deciding whether to invest or maintain an investment in shares of our common stock.
If any of the following risks actually occurs, our business, financial condition and results of operations would suffer. In this
case, the trading price of our common stock would likely decline. The risks described below are not the only ones we face.
Additional risks that we currently do not know about or that we currently believe to be immaterial also may impair our
business operations.
If we fail to grow our business internally or through strategic acquisitions we may be unable to execute our business plan,
maintain high levels of service or adequately address competitive challenges.
Our strategy is to continue internal growth and, as strategic opportunities arise in the workers’ compensation managed
care industry, to consider acquisitions of, or relationships with, other companies in related lines of business. As a result, we
are subject to certain growth-related risks, including the risk that we will be unable to retain personnel or acquire other
resources necessary to service such growth adequately. Expenses arising from our efforts to increase our market penetration
may have a negative impact on operating results. In addition, there can be no assurance that any suitable opportunities for
strategic acquisitions or relationships will arise or, if they do arise, that the transactions contemplated could be completed. If
such a transaction does occur, there can be no assurance that we will be able to integrate effectively any acquired business. In
addition, any such transaction would be subject to various risks associated with the acquisition of businesses, including, but
not limited to, the following:
•
an acquisition may negatively impact our results of operations because it may require incurring large one-time
charges, substantial debt or liabilities; it may require the amortization or write down of amounts related to
deferred compensation, goodwill and other intangible assets; or it may cause adverse tax consequences,
substantial depreciation or deferred compensation charges;
• we may encounter difficulties in assimilating and integrating the business, technologies, products, services,
personnel or operations of companies that are acquired, particularly if key personnel of the acquired company
decide not to work for us;
an acquisition may disrupt ongoing business, divert resources, increase expenses and distract management;
the acquired businesses, products, services or technologies may not generate sufficient revenue to offset
acquisition costs;
•
•
• we may have to issue equity or debt securities to complete an acquisition, which would dilute the position of
stockholders and could adversely affect the market price of our common stock; and
•
the acquisitions may involve the entry into a geographic or business market in which we have little or no
prior experience.
There can be no assurance that we will be able to identify or consummate any future acquisitions or other strategic
relationships on favorable terms, or at all, or that any future acquisition or other strategic relationship will not have an
adverse impact on our business or results of operations. If suitable opportunities arise, we may finance such transactions, as
well as internal growth, through debt or equity financing. There can be no assurance, however, that such debt or equity
financing would be available to us on acceptable terms when, and if, suitable strategic opportunities arise.
If we are unable to increase our market share among national and regional insurance carriers and large, self-funded
employers, our results may be adversely affected.
Our business strategy and future success depend in part on our ability to capture market share with our cost
containment services as national and regional insurance carriers and large, self-funded employers look for ways to achieve
cost savings. We cannot assure you that we will successfully market our services to these insurance carriers and employers or
that they will not resort to other means to achieve cost savings. Additionally, our ability to capture additional market share
may be adversely affected by the decision of potential customers to perform services internally instead of outsourcing the
provision of such services to us. Furthermore, we may not be able to demonstrate sufficient cost savings to potential or
current customers to induce them not to provide comparable services internally or to accelerate efforts to provide such
services internally.
11
If competition increases, our growth and profits may decline.
The markets for our network services and patient management services are also fragmented and competitive. Our
competitors include national managed care providers, preferred provider networks, smaller independent providers and
insurance companies. Companies that offer one or more workers’ compensation managed care services on a national basis are
our primary competitors. We also compete with many smaller vendors who generally provide unbundled services on a local
level, particularly companies with an established relationship with a local insurance company adjuster. In addition, several
large workers’ compensation insurance carriers offer managed care services for their customers, either by performance of the
services in-house or by outsourcing to organizations like ours. If these carriers increase their performance of these services
in-house, our business may be adversely affected. In addition, consolidation in the industry may result in carriers performing
more of such services in-house.
Our sequential revenue may not increase and may decline. As a result, we may fail to meet or exceed the expectations of
investors or analysts which could cause our common stock price to decline.
Our sequential revenue growth may not increase and may decline in the future as a result of a variety of factors, many
of which are outside of our control. If changes in our sequential revenue fall below the expectations of investors or analysts,
the price of our common stock could decline substantially. Fluctuations or declines in sequential revenue growth may be due
to a number of factors, including, but not limited to, those listed below and identified throughout this “Risk Factors” section:
the decline in manufacturing employment, the decline in workers’ compensation claims, the decline in healthcare
expenditures, the considerable price competition in a flat-to-declining workers’ compensation market, litigation, the increase
in competition, and the changes and the potential changes in state workers’ compensation and automobile-managed care laws
which can reduce demand for our services. These factors create an environment where revenue and margin growth is more
difficult to attain and where revenue growth is less certain than historically experienced. Additionally, our technology and
preferred provider network face competition from companies that have more resources available to them than we do. Also,
some customers may handle their managed care services in-house and may reduce the amount of services which are
outsourced to managed care companies such as CorVel. These factors could cause the market price of our common stock to
fluctuate substantially. There can be no assurance that our growth rate in the future, if any, will be at or near historical levels.
In addition, the stock market has in the past experienced price and volume fluctuations that have particularly affected
companies in the healthcare and managed care markets resulting in changes in the market price of the stock of many
companies, which may not have been directly related to the operating performance of those companies.
Due to the foregoing factors, and the other risks discussed in this report, investors should not rely on period-to-period
comparisons of our results of operations as an indication of our future performance.
The market price and trading volume of our common stock may be volatile, which could result in rapid and substantial
losses for our stockholders.
The market price of our common stock may be highly volatile and could be subject to wide fluctuations. In addition,
the trading volume in our common stock may fluctuate and cause significant price variations to occur. The stock market has
in the past experienced price and volume fluctuations that have particularly affected companies in the healthcare and
managed care markets resulting in changes in the market price of the stock of many companies, which may not have been
directly related to the operating performance of those companies. We cannot assure you that the market price of our common
stock will not fluctuate or decline significantly in the future.
12
We cannot assure our stockholders that our stock repurchase program will enhance long-term stockholder value and
stock repurchases, if any, could increase the volatility of the price of our common stock and will diminish our
cash reserves.
In 1996, our Board of Directors authorized a stock repurchase program and has periodically increased the number of
shares authorized for repurchase under the repurchase program. The most recent increase occurred in August 2013 and
brought the number of shares authorized for repurchase over the life of the program to 34,000,000 shares. There is no
expiration date for the repurchase program. The timing and actual number of shares repurchased, if any, depend on a variety
of factors including the timing of open trading windows, price, corporate and regulatory requirements, and other market
conditions. The program may be suspended or discontinued at any time without prior notice. Repurchases pursuant to our
stock repurchase program could affect our stock price and increase its volatility. The existence of a stock repurchase program
could also cause our stock price to be higher than it would be in the absence of such a program and could potentially reduce
the market liquidity for our stock. Additionally, repurchases under our stock repurchase program will diminish our cash
reserves, which could impact our ability to pursue possible future strategic opportunities and acquisitions and could result in
lower overall returns on our cash balances. There can be no assurance that any further stock repurchases will enhance
stockholder value because the market price of our common stock may decline below the levels at which we repurchased
shares of stock. Although our stock repurchase program is intended to enhance long-term stockholder value, short-term stock
price fluctuations could reduce the program’s effectiveness.
If the referrals for our patient management services decline, our business, financial condition and results of operations
would be materially adversely affected.
In some years, we have experienced a general decline in the revenue and operating performance of patient management
services. We believe that the performance decline has been due to the following factors: the decrease of the number of
workplace injuries that have become longer-term disability cases; increased regional and local competition from providers of
managed care services; a possible reduction by insurers on the types of services provided by our patient management
business; the closure of offices and continuing consolidation of our patient management operations; and employee turnover,
including management personnel, in our patient management business. In the past, these factors have all contributed to the
lowering of our long-term outlook for our patient management services. If some or all of these conditions continue, we
believe that the performance of our patient management revenues could decrease.
Declines in workers’ compensation claims may materially harm our results of operations.
Within the past few years, the economy has performed below historical averages which leads to fewer workers on a
national level and could lead to fewer work-related injuries. If declines in workers’ compensation costs occur in many states
and persist over the long-term, it would have a material adverse impact on our business, financial condition and results
of operations.
We provide an outsource service to payors of workers’ compensation and auto healthcare benefits. These payors
include insurance companies, TPAs, municipalities, state funds, and self-insured, self-administered employers. If these
payors reduce the amount of work they outsource, our results of operations would be materially adversely affected.
Healthcare providers are becoming increasingly resistant to the application of certain healthcare cost containment
techniques; this may cause revenue from our cost containment operations to decrease.
Healthcare providers have become more active in their efforts to minimize the use of certain cost containment
techniques and are engaging in litigation to avoid application of certain cost containment practices. Recent litigation between
healthcare providers and insurers has challenged certain insurers’ claims adjudication and reimbursement decisions. Although
these lawsuits do not directly involve us or any services we provide, these cases may affect the use by insurers of certain cost
containment services that we provide and may result in a decrease in revenue from our cost containment business.
13
Our failure to compete successfully could make it difficult for us to add and retain customers and could reduce or impede
the growth of our business.
We face competition from PPOs, TPAs and other managed healthcare companies. We believe that as managed care
techniques continue to gain acceptance in the workers’ compensation marketplace, our competitors will increasingly consist
of nationally-focused workers’ compensation managed care service companies, insurance companies, HMOs and other
significant providers of managed care products. Legislative reform in some states has been considered, but not enacted to
permit employers to designate health plans such as HMOs and PPOs to cover workers’ compensation claimants. Because
many health plans have the ability to manage medical costs for workers’ compensation claimants, such legislation may
intensify competition in the markets served by us. Many of our current and potential competitors are significantly larger and
have greater financial and marketing resources than we do, and there can be no assurance that we will continue to maintain
our existing customers, our past level of operating performance or be successful with any new products or in any new
geographical markets we may enter.
A breach of security may cause our customers to curtail or stop using our services.
We rely largely on our own security systems, confidentiality procedures and employee nondisclosure agreements to
maintain the privacy and security of our Company’s and our customers’ proprietary information. Accidental or willful
security breaches or other unauthorized access by third parties to our information systems, the existence of computer viruses
in our data or software and misappropriation of our proprietary information could expose us to a risk of information loss,
litigation and other possible liabilities which may have a material adverse effect on our business, financial condition and
results of operations. If security measures are breached because of third-party action, employee error, malfeasance or
otherwise, or if design flaws in our software are exposed and exploited, and, as a result, a third party obtains unauthorized
access to any customer data, our relationships with our customers and our reputation will be damaged, our business may
suffer and we could incur significant liability. Because techniques used to obtain unauthorized access or to sabotage systems
change frequently and generally are not recognized until launched against a target, we may be unable to anticipate these
techniques or to implement adequate preventative measures.
Exposure to possible litigation and legal liability may adversely affect our business, financial condition and results
of operations.
We, through our utilization management services, make recommendations concerning the appropriateness of providers’
medical treatment plans of patients throughout the country, and as a result, could be exposed to claims for adverse medical
consequences. We do not grant or deny claims for payment of benefits and we do not believe that we engage in the practice
of medicine or the delivery of medical services. There can be no assurance, however, that we will not be subject to claims or
litigation related to the authorization or denial of claims for payment of benefits or allegations that we engage in the practice
of medicine or the delivery of medical services.
In addition, there can be no assurance that we will not be subject to other litigation that may adversely affect our
business, financial condition or results of operations, including but not limited to being joined in litigation brought
against our customers in the managed care industry. We maintain professional liability insurance and such other
coverages as we believe are reasonable in light of our experience to date. If suc h insurance is insufficient or unavailable
in the future at reasonable cost to protect us from liability, our business, financial condition or results of operations
could be adversely affected.
If lawsuits against us are successful, we may incur significant liabilities.
We provide to insurers and other payors of healthcare costs managed care programs that utilize preferred provider
organizations and computerized bill review programs. Health care providers have brought, against us and our customers,
individual and class action lawsuits challenging such programs. If such lawsuits are successful, we may incur
significant liabilities.
We make recommendations about the appropriateness of providers’ proposed medical treatment plans for patients
throughout the country. As a result, we could be subject to claims arising from any adverse medical consequences. Although
plaintiffs have not to date subjected us to any claims or litigation relating to the granting or denial of claims for payment of
benefits or allegations that we engage in the practice of medicine or the delivery of medical services, we cannot assure you
that plaintiffs will not make such claims in future litigation. We also cannot assure you that our insurance will provide
sufficient coverage or that insurance companies will make insurance available at a reasonable cost to protect us from
significant future liability.
14
If the utilization by healthcare payors of early intervention services continues to increase, the revenue from our later-stage
network and healthcare management services could be negatively affected.
The performance of early intervention services, including injury occupational healthcare, first notice of loss, and
telephonic case management services, often result in a decrease in the average length of, and the total costs associated with, a
healthcare claim. By successfully intervening at an early stage in a claim, the need for additional cost containment services
for that claim often can be reduced or even eliminated. As healthcare payors continue to increase their utilization of early
intervention services, the revenue from our later stage network and healthcare management services will decrease.
An interruption in our ability to access critical data may cause customers to cancel their service and/or may reduce our
ability to effectively compete.
Certain aspects of our business are dependent upon our ability to store, retrieve, process and manage data and to
maintain and upgrade our data processing capabilities. Interruption of data processing capabilities for any extended length of
time, loss of stored data, programming errors or other system failures could cause customers to cancel their service and could
have a material adverse effect on our business and results of operations.
In addition, we expect that a considerable amount of our future growth will depend on our ability to process and
manage claims data more efficiently and to provide more meaningful healthcare information to customers and payors of
healthcare. There can be no assurance that our current data processing capabilities will be adequate for our future growth, that
we will be able to efficiently upgrade our systems to meet future demands, or that we will be able to develop, license or
otherwise acquire software to address these market demands as well or as timely as our competitors.
We face competition for staffing, which may increase our labor costs and reduce profitability.
We compete with other healthcare providers in recruiting qualified management and staff personnel for the day-to-day
operations of our business, including nurses and other case management professionals. In some markets, the scarcity of
nurses and other medical support personnel has become a significant operating issue to healthcare providers. This shortage
may require us to enhance wages to recruit and retain qualified nurses and other healthcare professionals. Our failure to
recruit and retain qualified management, nurses and other healthcare professionals, or to control labor costs could have a
material adverse effect on profitability.
The increased costs of professional and general liability insurance may have an adverse effect on our profitability.
The cost of commercial professional and general liability insurance coverage has risen significantly in the past several
years, and this trend may continue. In addition, if we were to suffer a material loss, our costs may increase over and above the
general increases in the industry. If the costs associated with insuring our business continue to increase, it may adversely
affect our business. We believe our current level of insurance coverage is adequate for a company of our size engaged in
our business.
Changes in government regulations could increase our costs of operations and/or reduce the demand for our services.
Many states, including a number of those in which we transact business, have licensing and other regulatory
requirements applicable to our business. Approximately half of the states have enacted laws that require licensing of
businesses which provide medical review services such as ours. Some of these laws apply to medical review of care covered
by workers’ compensation. These laws typically establish minimum standards for qualifications of personnel, confidentiality,
internal quality control and dispute resolution procedures. These regulatory programs may result in increased costs of
operation for us, which may have an adverse impact upon our ability to compete with other available alternatives for
healthcare cost control. In addition, new laws regulating the operation of managed care provider networks have been adopted
by a number of states. These laws may apply to managed care provider networks having contracts with us or to provider
networks which we may organize. To the extent we are governed by these regulations, we may be subject to additional
licensing requirements, financial and operational oversight and procedural standards for beneficiaries and providers.
15
Regulation in the healthcare and workers’ compensation fields is constantly evolving. We are unable to predict what
additional government initiatives, if any, affecting our business may be promulgated in the future. Our business may be
adversely affected by failure to comply with existing laws and regulations, failure to obtain necessary licenses and
government approvals or failure to adapt to new or modified regulatory requirements. Proposals for healthcare legislative
reforms are regularly considered at the federal and state levels. To the extent that such proposals affect workers’
compensation, such proposals may adversely affect our business, financial condition and results of operations.
In addition, changes in workers’ compensation, auto and managed health care laws or regulations may reduce demand
for our services, require us to develop new or modified services to meet the demands of the marketplace or reduce the fees
that we may charge for our services.
The introduction of software products incorporating new technologies and the emergence of new industry standards could
render our existing software products less competitive, obsolete or unmarketable.
There can be no assurance that we will be successful in developing and marketing new software products that respond
to technological changes or evolving industry standards. If we are unable, for technological or other reasons, to develop and
introduce new software products cost-effectively, in a timely manner and in response to changing market conditions or
customer requirements, our business, results of operations and financial condition may be adversely affected.
Developing or implementing new or updated software products and services may take longer and cost more than
expected. We rely on a combination of internal development, strategic relationships, licensing and acquisitions to develop our
software products and services. The cost of developing new healthcare information services and technology solutions is
inherently difficult to estimate. Our development and implementation of proposed software products and services may take
longer than originally expected, require more testing than originally anticipated and require the acquisition of additional
personnel and other resources. If we are unable to develop new or updated software products and services cost-effectively on
a timely basis and implement them without significant disruptions to the existing systems and processes of our customers, we
may lose potential sales and harm our relationships with current or potential customers.
The failure to attract and retain qualified or key personnel may prevent us from effectively developing, marketing, selling,
integrating and supporting our services.
We are dependent, to a substantial extent, upon the continuing efforts and abilities of certain key management
personnel. In addition, we face competition for experienced employees with professional expertise in the workers’
compensation managed care area. The loss of key personnel, especially V. Gordon Clemons, Sr., our Chairman, President,
and Chief Executive Officer, or the inability to attract qualified employees, could have a material unfavorable effect on our
business and results of operations.
If we lose several customers in a short period, our results may be materially adversely affected.
Our results may decline if we lose several customers during a short period. Most of our customer contracts permit
either party to terminate without cause. If several customers terminate, or do not renew or extend their contracts with us, our
results could be materially and adversely affected. Many organizations in the insurance industry have consolidated and this
could result in the loss of one or more of our customers through a merger or acquisition. Additionally, we could lose
customers due to competitive pricing pressures or other reasons.
We are subject to risks associated with acquisitions of intangible assets.
Our acquisition of other businesses may result in significant increases in our intangible assets and goodwill. We
regularly evaluate whether events and circumstances have occurred indicating that any portion of our intangible assets and
goodwill may not be recoverable. When factors indicate that intangible assets and goodwill should be evaluated for possible
impairment, we may be required to reduce the carrying value of these assets. We cannot currently estimate the timing and
amount of any such charges.
16
If we are unable to leverage our information systems to enhance our outcome-driven service model, our results may be
adversely affected.
To leverage our knowledge of workplace injuries, treatment protocols, outcomes data, and complex regulatory
provisions related to the workers’ compensation market, we must continue to implement and enhance information systems
that can analyze our data related to the workers’ compensation industry. We frequently upgrade existing operating systems
and are updating other information systems that we rely upon in providing our services and financial reporting. We have
detailed implementation schedules for these projects that require extensive involvement from our operational, technological
and financial personnel. Delays or other problems we might encounter in implementing these projects could adversely affect
our ability to deliver streamlined patient care and outcome reporting to our customers.
Our Internet-based services are dependent on the development and maintenance of the Internet infrastructure.
The Internet has experienced a variety of outages and other delays as a result of damages to portions of its
infrastructure, and it could face outages and delays in the future. These outages and delays could reduce the level of Internet
usage, as well as the availability of the Internet to us for delivery of our Internet-based services. In addition, our customers
who use our Web-based services depend on Internet service providers, online service providers and other website operators
for access to our website. All of these providers have experienced significant outages in the past and could experience
outages, delays and other difficulties in the future due to system failures unrelated to our systems. Any significant
interruptions in our services or increases in response time could result in a loss of potential or existing users, and, if sustained
or repeated, could reduce the attractiveness of our services.
We are sensitive to regional weather conditions that may adversely affect our operations.
Our operations are directly affected in the short term by the weather conditions in certain regions of operation.
Therefore our business is sensitive to the weather conditions of these regions. Unusually inclement weather, including
significant rain, snow, sleet, freezing rain or ice can temporarily affect our operations if clients are forced to close operational
centers. Accordingly, our operating results may vary from quarter to quarter, depending on the impact of these
weather conditions.
Natural and other disasters may adversely affect our business.
We may be vulnerable to damage from severe weather conditions or natural disasters, including hurricanes, fires,
floods, earthquakes, power loss, communications failures and similar events, including the effects of war or acts of
terrorism. If a disaster were to occur, our ability to operate our business could be seriously or completely impaired or
destroyed. The insurance we maintain may not be adequate to cover our losses resulting from disasters or other
business interruptions.
Item 1B.
Unresolved Staff Comments
None.
Item 2.
Properties.
The Company’s principal executive office is located in Irvine, California in approximately 13,000 square feet of leased
space. The lease expires in January 2020. The Company leases approximately 87 branch offices in 43 states, which range in
size from 200 square feet up to 94,000 square feet. The lease terms for the branch offices range from monthly to ten years and
expire at various dates through 2023. The Company believes that its facilities are adequate for its current needs and that
suitable additional space will be available as required.
Item 3.
Legal Proceedings.
The Company is involved in litigation arising in the normal course of business. Management believes that resolution of
these matters will not result in any payment that, in the aggregate, would be material to the financial position or results of the
operations of the Company.
Item 4.
Mine Safety Disclosures.
Not applicable.
17
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities.
Market Information
The Company’s common stock is traded on the NASDAQ Global Select Market under the symbol CRVL. The
quarterly high and low per share sales prices for the Company’s common stock for fiscal years 2014 and 2015 as reported by
NASDAQ are set forth below for the periods indicated. These prices represent prices among dealers, do not include retail
markups, markdowns or commissions, and may not represent actual transactions.
High
Low
Fiscal Year Ended March 31, 2014:
Quarter Ended June 30, 2013: .....................................................................................................................................................................................
Quarter Ended September 30, 2013: ...........................................................................................................................................................................
Quarter Ended December 31, 2013: ............................................................................................................................................................................
Quarter Ended March 31, 2014:..................................................................................................................................................................................
$ 22.58
29.17
36.15
44.12
$ 30.00
37.29
48.61
53.35
Fiscal Year Ended March 31, 2015:
Quarter Ended June 30, 2014: .....................................................................................................................................................................................
Quarter Ended September 30, 2014: ...........................................................................................................................................................................
Quarter Ended December 31, 2014: ............................................................................................................................................................................
Quarter Ended March 31, 2015:..................................................................................................................................................................................
$ 42.18
28.08
31.47
31.91
$ 52.63
47.21
38.34
37.93
Holders. As of June 5, 2015, there were approximately 1,030 holders of record of the Company’s common stock
according to the information provided by the Company’s transfer agent.
Dividends. The Company has never paid any cash dividends on its common stock and has no current plans to do so in
the foreseeable future. The Company intends to retain future earnings, if any, for use in the Company’s business. The
payment of any future dividends on its common stock will be determined by the Board of Directors in light of conditions then
existing, including the Company’s earnings, financial condition and requirements, restrictions in financing agreements,
business conditions and other factors.
Unregistered Sales of Equity Securities. None.
Issuer Purchases of Equity Securities: The following table summarizes purchases of the Company’s common stock
made by or on behalf of the Company for the quarter ended March 31, 2015 pursuant to a publicly announced plan.
Total
Number of
Shares
Purchased
Average Price
Paid Per
Share
Total Number of Shares
Purchased as Part of
Publicly Announced
Program
Maximum Number of
Shares that may yet
be Purchased Under
the Program
Period
January 1 to January 31, 2015 ....................................................................................................................................................................................
February 1 to
1,182,245
85,846
85,846
34.91
$
February 28, 2015 ..................................................................................................................................................................................................
March 1 to March 31, 2015 ........................................................................................................................................................................................
1,101,843
1,007,512
80,402
94,331
80,402
94,331
35.39
34.95
Total ...........................................................................................................................................................................................................................
1,007,512
260,579
260,579
35.07
$
In 1996, the Company’s Board of Directors authorized a stock repurchase program initially for up to 100,000 shares of
the Company’s common stock. The Company’s Board of Directors has periodically increased the number of shares
authorized for repurchase under the program. In August 2013, the board authorized an increase in the number of shares to be
repurchased over the life of the program to 34,000,000. As of March 31, 2015, the Company has repurchased 32,992,488
shares of its common stock over the life of the program. There is no expiration date for the plan.
18
STOCK PERFORMANCE GRAPH
The graph depicted below shows a comparison of cumulative total stockholder returns for the Company, the NASDAQ
and the NASDAQ Health Services Index over a five year period beginning on March 31, 2010. The data depicted on the
graph are as set forth in the chart below the graph. The graph assumes that $100 was invested in the Company’s Common
Stock on March 31, 2010, and in each index, and that all dividends were reinvested. No cash dividends have been paid or
declared on the Common Stock. Stockholder returns over the indicated period should not be considered indicative of future
stockholder returns.
2010
2011
2012
2013
2014
2015
CorVel Corporation ....................................................................................................................................................................................................
U.S. NASDAQ............................................................................................................................................................................................................
U.S. NASDAQ Healthcare Services ...........................................................................................................................................................................
278.38
175.11
217.88
148.76
115.98
106.93
138.43
136.26
157.00
192.50
204.38
294.80
100.00
100.00
100.00
111.58
128.93
122.28
Notwithstanding anything to the contrary set forth in any of our previous filings made under the Securities Act of 1933,
as amended, or the Securities Exchange Act of 1934, as amended, that might incorporate future filings made by us under
those statutes, neither the preceding Stock Performance Graph, nor the information relating to it, is “soliciting material” or is
“filed” or is to be incorporated by reference into any such prior filings, nor shall such graph or information be incorporated
by reference into any future filings made by us under those statutes.
Item 6.
Selected Financial Data.
The selected consolidated financial data of the Company appears in a separate section of this Annual Report on Form
10-K immediately preceding the Management’s Discussion and Analysis of Financial Condition and Results of Operations
section and is incorporated herein by this reference.
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Management’s Discussion and Analysis of Financial Condition and Results of Operations appears in a separate section
of this Annual Report on Form 10-K and is incorporated herein by this reference.
19
Item 7A.
Quantitative and Qualitative Disclosures About Market Risk.
As of March 31, 2015, the Company held no market risk sensitive instruments for trading purposes and the Company
did not employ any derivative financial instruments, other financial instruments, or derivative commodity instruments to
hedge any market risk.
Item 8.
Financial Statements and Supplementary Data.
The Company’s consolidated financial statements, as listed under Item 15, appear in a separate section of this Annual
Report on Form 10-K and are incorporated herein by this reference. The financial statement schedule is included below
under Item 15(a) (2).
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
None.
Item 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial
Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-
15(e) under the Exchange Act). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer
concluded that, as of March 31, 2015, our disclosure controls and procedures were effective in ensuring that information
required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is (i) recorded, processed,
summarized and reported, within the time periods specified in the Commission’s rules and forms and (ii) accumulated and
communicated to our management, including our principal executive and principal accounting officers, or persons
performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining a system of internal control over financial reporting as
defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Internal control over financial reporting is designed to
provide reasonable assurance regarding the reliability of our financial reporting and preparation of financial statements for
external purposes in accordance with accounting principles generally accepted in the United States of America. Internal
control over financial reporting includes maintaining records that in reasonable detail accurately and fairly reflect our
transactions; providing reasonable assurance that transactions are recorded as necessary for preparation of our financial
statements in accordance with accounting principles generally accepted in the United States of America; providing reasonable
assurance that our receipts and expenditures are made in accordance with authorizations of our management and directors;
and providing reasonable assurance that unauthorized acquisition, use or disposition of our assets that could have a material
effect on our financial statements would be prevented or detected on a timely basis.
Management conducted an assessment of the effectiveness of our internal control over financial reporting based on the
framework set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in the 2013
Internal Control — Integrated Framework (“2013 COSO framework”). Based on this assessment, our management
concluded that our internal control over financial reporting was effective as of March 31, 2015 to provide reasonable
assurance regarding the reliability of financial reporting and preparation of financial statements for external reporting
purposes in accordance with accounting principles generally accepted in the United States of America.
Our independent registered public accounting firm, Haskell & White LLP, has issued an audit report on the
effectiveness of our internal control over financial reporting as of March 31, 2015 as stated in their report that is included in
Part II, Item 8 herein.
Changes to Internal Control over Financial Reporting
We completed a transition to the new 2013 COSO framework by performing an assessment of our Internal Control
over financial reporting and reviewing compliance with the 17 principles outlined by the 2013 COSO framework.
Compliance with the 2013 COSO framework was obtained through enhancing our control documentation, because all of the
procedures that were added to our controls documentation were procedures already in place at our Company and have been
and continue to be part of our day-to-day operations.
20
During the quarter ended June 30, 2014, Richard J. Schweppe replaced Scott McCloud as our Chief Financial Officer,
and a Form 8-K was filed disclosing this change. Certain control responsibilities have been reassigned to certain key
personnel within our Company. Management has reviewed and will continue to monitor our internal controls to make sure
there is no adverse impact. There have been no other changes in our internal controls over financial reporting (as defined in
Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) during the fiscal quarter ended March 31, 2015
that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 9B.
Other Information.
None.
21
PART III
Item 10.
Directors, Executive Officers and Corporate Governance.
The information in the sections titled “Proposal One: Election of Directors,” “Corporate Governance, Board
Composition and Board Committees,” “Executive Officers of CorVel,” and “Section 16(a) Beneficial Ownership Reporting
Compliance” appearing in the Company’s Definitive Proxy Statement for the 2015 Annual Meeting of Stockholders is
incorporated herein by reference.
The Board of Directors has adopted a code of ethics and business conduct that applies to all of the Company’s
employees, officers and directors. The full text of the Company’s code of ethics and business conduct is posted on the
Company’s web site at www.corvel.com under the “Investor Relations” section. The Company intends to disclose future
amendments to certain provisions of the Company’s code of ethics and business conduct, or waivers of such provisions,
applicable to the Company’s directors and executive officers, at the same location on the Company’s web site identified
above. The inclusion of the Company’s web site address in this report does not include or incorporate by reference the
information on the Company’s web site into this report.
Item 11.
Executive Compensation.
The information in the sections titled “Executive Compensation,” “Compensation Discussion and Analysis,”
“Compensation Committee Interlocks and Insider Participation,” “Compensation Committee Report,” and “Compensation of
Directors,” appearing in the Company’s Definitive Proxy Statement for the 2015 Annual Meeting of Stockholders is
incorporated herein by reference.
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The information in the sections titled “Security Ownership of Certain Beneficial Owners and Management and Related
Stockholder Matter” and “Equity Compensation Plan Information” appearing in the Company’s Definitive Proxy Statement
for the 2015 Annual Meeting of Stockholders is incorporated herein by reference.
Item 13.
Certain Relationships and Related Party Transactions, and Director Independence.
The information in the sections titled “Certain Relationships and Related Person Transactions,” “Proposal One:
Election of Directors,” and “Corporate Governance, Board Composition and Board Committees” appearing in the Company’s
Definitive Proxy Statement for the 2015 Annual Meeting of Stockholders is incorporated herein by reference.
Item 14.
Principal Accounting Fees and Services.
The information under the captions “Principal Accountant Fees and Services”, “Audit Committee Pre-Approval of
Audit and Permissible Non-Audit Services of Independent Auditors” and “Ratification of Appointment of Independent
Auditors” appearing in the Company’s Definitive Proxy Statement for the 2015 Annual Meeting of Stockholders is
incorporated herein by reference.
22
Item 15.
Exhibits, Financial Statement Schedules.
(a)(1) Financial Statements:
PART IV
The Company’s financial statements appear in a separate section of this Annual Report on Form 10-K beginning on the
pages referenced below:
Report of Independent Registered Public Accounting Firm .......................................................................................................................................
42
Consolidated Statements of Income for the Fiscal Years Ended March 31, 2013, 2014, and 2015 ...........................................................................
43
Consolidated Balance Sheets as of March 31, 2014 and 2015....................................................................................................................................
44
Consolidated Statements of Stockholders’ Equity for the Fiscal Years Ended March 31, 2013, 2014, and 2015 ......................................................
45
Consolidated Statements of Cash Flows for the Fiscal Years Ended March 31, 2013, 2014, and 2015 .....................................................................
46
Notes to Consolidated Financial Statements ...............................................................................................................................................................
47
Page
(2) Financial Statement Schedule:
The Company’s consolidated financial statements, as listed under Item 15(a) (1), appear in a separate section of this
Annual Report on Form 10-K. The Company’s financial statement schedule is as follows:
Schedule II — Valuation and Qualifying Accounts
Balance at
Beginning of Year
Additions
Charged to Cost
and Expenses
Deductions
Balance at End
of Year
Allowance for doubtful accounts:
Fiscal Year Ended March 31, 2015: ...........................................................................................................................................................................
1,730,000
Fiscal Year Ended March 31, 2014: ...........................................................................................................................................................................
1,332,000
Fiscal Year Ended March 31, 2013: ...........................................................................................................................................................................
2,123,000
1,745,000 $
2,295,000
2,395,000
$ 1,645,000
1,745,000
2,295,000
$ (1,830,000)
(1,882,000)
(2,223,000)
$
23
(3) Exhibits:
Exhibit
No.
3.1
Amended and Restated Certificate of Incorporation
of the Company
3.2
Amended and Restated Bylaws of the Company
3.3
4.1
Certificate of Designation Increasing the Number
of Shares of Series A Junior Participating
Preferred Stock
Second Amended and Restated Preferred Shares
Rights Agreement, dated as of November 17, 2008,
by and between CorVel Corporation and
Computershare Trust Company, N.A., including the
original Certificate of Designation, the Certificate of
Designation Increasing the Number of Shares, the
form of Right Certificate (as amended) and the
Summary of Rights (as amended) attached thereto as
Exhibits A-1, A-2, A-3, B and C, respectively
EXHIBITS
Title
Method of
Filing
Incorporated herein by reference to Exhibit 3.1 to the
Company’s Current Report on Form 8-K filed on
August 10, 2011.
Incorporated herein by reference to Exhibit 3.2 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended June 30, 2006 filed on
August 14, 2006.
Incorporated herein by reference to Exhibit 3.1 to the
Company’s Form 8-K filed on November 24, 2008.
Incorporated herein by reference to Exhibit 4.1 to the
Company’s Form 8-K filed on November 24, 2008.
10.1*
Nonqualified Stock Option Agreement between V.
Gordon Clemons, Sr., the Company and North Star
together with all amendments and
addendums thereto
Incorporated herein by reference to Exhibit 10.6 to the
Company’s Registration Statement on Form S-1
Registration No. 33-40629 initially filed on
May 16, 1991.
10.2*
Supplementary Agreement between V. Gordon
Clemons, Sr., the Company and North Star
Incorporated herein by reference to Exhibit 10.7 to the
Company’s Registration Statement on Form S-1
Registration No. 33-40629 initially filed on
May 16, 1991.
10.3*
Amendment to Supplementary Agreement between
V. Gordon Clemons, Sr., the Company and
North Star
Incorporated herein by reference to Exhibit 10.5 to the
Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 1992 filed on June 29, 1992.
10.4*
Restated Omnibus Incentive Plan (Formerly The
Restated 1988 Executive Stock Option Plan)
10.5*
Forms of Notice of Grant of Stock Option, Stock
Option Agreement and Notice of Exercise Under
the Restated Omnibus Incentive Plan (Formerly
The Restated 1988 Executive Stock Option)
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on
August 10, 2011.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended September 30, 2006 filed on
November 9, 2006, Exhibits 10.7, 10.8 and 10.9 to the
Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 1994 filed on June 29, 1994,
Exhibits 99.2, 99.3, 99.4, 99.5, 99.6, 99.7 and 99.8 to
the Company’s Registration Statement on Form S-8
(File No. 333-94440) filed on July 10, 1995, and
Exhibits 99.3 and 99.5 to the Company’s Registration
Statement on Form S-8 (File No. 333-58455) filed on
July 2, 1998.
24
Method of
Filing
Incorporated herein by reference to Exhibit 10.12 to
the Company’s Registration Statement on Form S-1
Registration No. 33-40629 initially filed on
May 16, 1991.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K/A filed on
August 12, 2010.
Incorporated herein by reference to Exhibits 10.16 and
10.16A to the Company’s Registration Statement on
Form S-1 Registration No. 33-40629 initially filed on
May 16, 1991.
Incorporated herein by reference to Exhibit 4.1 to the
Company’s Form 8-K filed on November 24, 2008.
Exhibit
No.
10.6*
Title
Employment Agreement of V. Gordon
Clemons, Sr.
10.7*
Restated 1991 Employee Stock Purchase
Plan, as amended
10.8
Fidelity Master Plan for Savings and Investment,
and amendments
Second Amended and Restated Preferred Shares
Rights Agreement, dated as of November 17, 2008,
by and between CorVel Corporation and
Computershare Trust Company, N.A., including
the original Certificate of Designation, the
Certificate of Designation Increasing the Number
of Shares, the form of Rights Certificate (as
amended) and the Summary of Rights (as
amended) attached thereto as Exhibits A-1, A-2,
A-3, B and C, respectively
10.9
10.10
10.11
Credit Agreement dated May 28, 2009 by and
between CorVel Corporation and Wells Fargo
Bank, National Association.
Incorporated herein by reference to Exhibit 10.16 to
the Company’s Current Report on Form 8-K filed on
June 4, 2009.
Revolving Line of Credit Note dated May 28, 2009
by CorVel Corporation in favor of Wells Fargo
Bank, National Association.
Incorporated herein by reference to Exhibit 10.17 to
the Company’s Current Report on Form 8-K filed on
June 4, 2009.
10.12
Form of Partial Waiver of Automatic Option Grant
executed by Directors
10.13
Partial Waiver of Automatic Option Grant by Jean
H. Macino dated February 8, 2008
Incorporated herein by reference to Exhibit 10.18 to
the Company’s Quarterly Report on Form 10-Q for the
quarterly period ended September 30, 2007 filed on
November 8, 2007.
Incorporated herein by reference to Exhibit 10.22 to
the Company’s Annual Report on Form 10-K for the
fiscal year ended March 31, 2008 filed on
June 16, 2008.
10.14
10.15
10.16*
10.17
First Amendment to Credit Agreement dated
June 2, 2010 by and between CorVel Corporation
and Wells Fargo Bank, National Association.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on
June 7, 2010.
Revolving Line of Credit Note dated June 2, 2010
by CorVel Corporation in favor of Wells Fargo
Bank, National Association.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Current Report on Form 8-K filed on
June 7, 2010.
Stock Option Agreement dated December 6, 2010
between the company and Diane J. Blaha,
providing performance vesting.
Second Amendment to Credit Agreement dated
September 1, 2011 by and between CorVel
Corporation and Wells Fargo Bank,
National Association.
Incorporated herein by reference to Exhibit 10.32 to
the Company’s Annual Report on Form 10-K for the
fiscal year ended March 31, 2014 filed on
June 12, 2014.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on
August 31, 2011.
25
Exhibit
No.
10.18
Title
Method of
Filing
Revolving Line of Credit Note dated September 1,
2011 by CorVel Corporation in favor of Wells
Fargo Bank, National Association.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Current Report on Form 8-K filed on
August 31, 2011.
10.19*† Stock option agreement dated November 3, 2011,
Refiled herewith.
10.20
10.21
between the Company and Diane J. Blaha,
providing performance vesting.
Third Amendment to Credit Agreement dated
September 1, 2012 by and between CorVel
Corporation and Wells Fargo Bank,
National Association.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on
September 7, 2012.
Revolving Line of Credit Note dated September 1,
2012 by CorVel Corporation in favor of Wells
Fargo Bank, National Association.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Current Report on Form 8-K filed on
September 7, 2012.
10.22*† Stock option agreement dated March 1, 2013,
Refiled herewith.
between the Company and V. Gordon Clemons,
Sr., providing performance vesting.
10.23*† Stock option agreement dated March 1, 2013,
Refiled herewith.
between the Company and Scott McCloud,
providing performance vesting.
10.24*† Stock option agreement dated March 1, 2013,
Refiled herewith.
between the Company and Donald C. McFarlane,
providing performance vesting.
10.25*† Stock option agreement dated March 1, 2013,
Refiled herewith.
10.26
10.27
between the Company and Diane J. Blaha,
providing performance vesting.
Fourth Amendment to Credit Agreement dated
September 1, 2013 by and between CorVel
Corporation and Wells Fargo Bank,
National Association.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on
September 5, 2013.
Revolving Line of Credit Note dated September 1,
2013 by CorVel Corporation in favor of Wells
Fargo Bank, National Association.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Current Report on Form 8-K filed on
September 5, 2013.
10.28*† Stock option agreement dated November 4, 2013,
Refiled herewith.
between the Company and Scott McCloud,
providing performance vesting.
10.29*† Stock option agreement dated November 4, 2013,
between the Company and Donald C. McFarlane,
providing performance vesting.
Refiled herewith.
10.30*† Stock option agreement dated November 4, 2013,
Refiled herewith.
between the Company and Diane J. Blaha,
providing performance vesting.
10.31*† Stock option agreement dated November 4, 2013,
between the Company and Richard J. Schweppe,
providing performance vesting.
Refiled herewith.
10.32*† Stock option agreement dated March 1, 2013,
Refiled herewith
between the Company and Richard J. Schweppe,
providing performance vesting.
26
Exhibit
No.
10.33
10.34
Title
Fifth Amendment to Credit Agreement dated
September 1, 2014 by and between CorVel
Corporation and Wells Fargo Bank,
National Association.
Method of
Filing
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Current Report on Form 8-K filed on
September 5, 2014.
Revolving Line of Credit Note dated September 1,
2014 by CorVel Corporation in favor of Wells
Fargo Bank, National Association.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Current Report on Form 8-K filed on
September 5, 2014.
10.35*† Stock option agreement dated November 19, 2014,
between the Company and Richard J. Schweppe,
providing performance vesting.
10.36*† Stock option agreement dated November 19, 2014,
between the Company and Diane J. Blaha,
providing performance vesting.
Incorporated herein by reference to Exhibit 10.1 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended December 31, 2014 filed on
February 5, 2015.
Incorporated herein by reference to Exhibit 10.2 to the
Company’s Quarterly Report on Form 10-Q for the
quarterly period ended December 31, 2014 filed on
February 5, 2015.
Filed herewith
Filed herewith.
Filed herewith.
Filed herewith.
Furnished herewith.
Furnished herewith.
21.1
23.1
31.1
31.2
32.1
32.2
101.0
Subsidiaries of the Company
Consent of Independent Registered Public
Accounting Firm, Haskell & White LLP.
Certification of the Chief Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
Certification of the Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
Certification of the Chief Executive Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
Certification of the Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
The following materials from CorVel
Corporation’s Annual Report on Form 10-K for the
fiscal year ended March 31, 2015, formatted in
XBRL (eXtensible Business Reporting Language):
(i) Consolidated Balance Sheets as of March 31,
2015 and March 31, 2014; (ii) Consolidated
Statements of Income for the fiscal years ended
March 31, 2015, 2014 and 2013; (iii) Consolidated
Statements of Stockholders’ Equity for the fiscal
years ended March 31, 2015, 2014 and 2013; (iv)
Consolidated Statements of Cash Flows for the
fiscal years ended March 31, 2015, 2014 and 2013;
and (v) Notes to Consolidated Financial Statements
*
†
– Denotes management contract or compensatory plan or arrangement.
– Confidential treatment has been requested for certain confidential portions of this exhibit pursuant to Rule 24b-2
under the Securities Exchange Act of 1934. In accordance with Rule 24b-2, these confidential portions have been
omitted from this exhibit and filed separately with the Securities and Exchange Commission.
27
(b) Exhibits
The exhibits filed as part of this report are listed under Item 15(a)-(3) of this Annual Report on Form 10-K.
(c) Financial Statement Schedule
The Financial Statement Schedules required by Regulation S-X and Item 8 of Form 10-K are listed under Item 15(a)(2) of
this Annual Report on Form 10-K.
28
Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SIGNATURES
CORVEL CORPORATION
By:
/S/ V. GORDON CLEMONS, SR.
V. Gordon Clemons, Sr.
Chairman of the Board, President, and Chief Executive Officer
Date: June 11, 2015
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the
following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature
Title
Date
/S/ V. GORDON CLEMONS, SR.
V. Gordon Clemons, Sr.
Chairman of the Board, Chief Executive
Officer, and President
(Principal Executive Officer)
June 11, 2015
/S/ RICHARD J. SCHWEPPE
Richard J. Schweppe
/S/ ALAN R. HOOPS
Alan R. Hoops
/S/ STEVEN J. HAMERSLAG
Steven J. Hamerslag
/S/ R. JUDD JESSUP
R. Judd Jessup
/S/ JEAN H. MACINO
Jean H. Macino
/S/ JEFFREY J. MICHAEL
Jeffrey J. Michael
Chief Financial Officer (Principal
Financial and Accounting Officer)
June 11, 2015
Director
June 11, 2015
Director
June 11, 2015
Director
June 11, 2015
Director
June 11, 2015
Director
June 11, 2015
29
SELECTED CONSOLIDATED FINANCIAL DATA
The following selected financial data for each of the five fiscal years ended March 31, 2015, have been derived from
the Company’s audited consolidated financial statements. The following data should be read in conjunction with the
Company’s Consolidated Financial Statements, the related notes thereto, and “Management’s Discussion and Analysis of
Financial Condition and Results of Operations.” The following amounts are in thousands, except per share data.
2011
2012
2013
2014
2015
Fiscal Year Ended March 31,
Statement of Income Data:
Revenues .....................................................................................................................................................................................................................
Cost of revenues .........................................................................................................................................................................................................
$ 478,816
370,335
$ 412,668
318,826
$ 380,668
284,098
$ 429,310
337,650
$ 492,625
392,656
Gross profit .................................................................................................................................................................................................................
93,842
General and administrative .........................................................................................................................................................................................
50,405
108,481
51,974
96,570
59,167
91,660
47,765
99,969
54,405
Income before income taxes .......................................................................................................................................................................................
43,437
Income tax provision ..................................................................................................................................................................................................
16,885
56,507
22,115
37,403
12,740
43,895
17,165
45,564
16,974
Net income ..................................................................................................................................................................................................................
$ 34,392
$ 26,552
$ 24,663
$ 26,730
$ 28,590
Net income per share:
Basic ...........................................................................................................................................................................................................................
1.16
1.63
1.38
1.20
1.05
$
$
$
$
$
Diluted ........................................................................................................................................................................................................................
1.14
1.61
1.37
1.03
1.19
$
$
$
$
$
Shares used in computing net income per
share:
Basic ...........................................................................................................................................................................................................................
22,952
Diluted ........................................................................................................................................................................................................................
23,254
Return on beginning of year equity ............................................................................................................................................................................
Return on beginning of year assets .............................................................................................................................................................................
21,104
21,372
23,602
24,058
22,256
22,458
20,669
20,890
30.9%
18.9%
26.6%
16.2%
22.6%
13.3%
24.2%
15.6%
25.8%
17.6%
2011
2012
2013
2014
2015
Balance Sheet Data as of March 31,
Cash and cash equivalents ..........................................................................................................................................................................................
6,597
Accounts receivable, net .............................................................................................................................................................................................
49,334
Working capital ..........................................................................................................................................................................................................
36,485
Total assets .................................................................................................................................................................................................................
171,882
Retained earnings ........................................................................................................................................................................................................
275,046
Treasury stock .............................................................................................................................................................................................................
(270,574)
Total stockholders’ equity ..........................................................................................................................................................................................
110,382
$ 34,866
57,229
49,120
214,481
336,168
(328,480)
126,522
$ 12,269
48,964
27,389
164,225
248,494
(248,931)
99,639
$ 19,822
49,105
40,145
182,382
301,776
(301,301)
111,402
$ 25,516
57,537
45,140
218,754
364,758
(360,278)
127,923
$
30
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Management’s Discussion and Analysis of Financial Condition and Results of Operations may include certain
forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E
of the Securities Exchange Act of 1934, as amended, including (without limitation) statements with respect to anticipated
future operating and financial performance, growth and acquisition opportunities and other similar forecasts and statements
of expectation. Words such as “expects,” “anticipates,” “intends,” “plans,” “predicts,” “believes,” “seeks,” “estimates,”
“potential,” “continue,” “strive,” “ongoing,” “may,” “will,” “would,” “could,” and “should” and variations of these words
and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements made by the
Company and its management are based on estimates, projections, beliefs and assumptions of management at the time of
such statements and are not guarantees of future performance.
The Company disclaims any obligations to update or revise any forward-looking statement based on the occurrence of
future events, the receipt of new information or otherwise. Actual future performance, outcomes and results may differ
materially from those expressed in forward-looking statements made by the Company and its management as a result of a
number of risks, uncertainties and assumptions. Representative examples of these factors include (without limitation) general
industry and economic conditions, including a decreasing number of national claims due to a decreasing number of injured
workers; cost of capital and capital requirements; existing and possible litigation and legal liability in the course of operations
and the Company’s ability to resolve such litigation; cost of capital and capital requirements; competition from other
managed care companies; the ability to expand certain areas of the Company’s business; shifts in customer demands; the
ability of the Company to produce market-competitive software; changes in operating expenses including employee wages,
benefits and medical inflation; governmental and public policy changes, including but not limited to legislative and
administrative law and rule implementation or change; dependence on key personnel; the continued availability of financing
in the amounts and at the terms necessary to support the Company’s future business; and the other risks identified under the
heading “Risk Factors” appearing elsewhere in the report.
Overview
CorVel Corporation is an independent nationwide provider of medical cost containment and managed care services
designed to address the escalating medical costs of workers’ compensation and auto claims. The Company’s services are
provided to insurance companies, third-party administrators (“TPA’s”), governmental entities, and self-administered
employers to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims.
Network Solutions Services
The Company’s network solutions services are designed to reduce the price paid by its customers for medical services
rendered in workers’ compensation cases, auto policies and, to a lesser extent, group health policies. The network solutions
offered by the Company include automated medical fee auditing, preferred provider services, retrospective utilization review,
independent medical examinations, and inpatient bill review. Network solutions services also includes revenue from the
Company’s directed care network (CareIQ), including imaging and physical therapy.
Patient Management Services
In addition to its network solutions services, the Company offers a range of patient management services, which
involve working on a one-on-one basis with injured employees and their various healthcare professionals, employers and
insurance company adjusters. The services are designed to monitor the medical necessity and appropriateness of healthcare
services provided to workers’ compensation and other healthcare claimants and to expedite return to work. The Company
offers these services on a stand-alone basis, or as an integrated component of its medical cost containment services. Patient
management services include the processing of claims for self-insured payors to property and casualty insurance.
Organizational Structure
The Company’s management is structured geographically with regional vice-presidents who report to the Chief
Executive Officer of the Company. Each of these regional vice-presidents is responsible for all services provided by the
Company in his or her particular region and responsible for the operating results of the Company in multiple states. These
regional vice presidents have area and district managers who are also responsible for all services provided by the Company in
their given area and district.
31
Business Enterprise Segments
The Company operates in one reportable operating segment, managed care. The Company’s services are delivered to
its customers through its local offices in each region and financial information for the Company’s operations follows this
service delivery model. All regions provide the Company’s patient management and network solutions services. FASB ASC
280-10 establishes standards for the way that public business enterprises report information about operating segments in
annual and interim consolidated financial statements. The Company’s internal financial reporting is segmented
geographically, as discussed above, and managed on a geographic rather than service line basis, with virtually all of the
Company’s operating revenue generated within the United States.
Under FASB ASC 280-10, two or more operating segments may be aggregated into a single operating segment for
financial reporting purposes if aggregation is consistent with the objective and basic principles, if the segments have similar
economic characteristics, and if the segments are similar in each of the following areas: 1) the nature of products and
services; 2) the nature of the production processes; 3) the type or class of customer for their products and services; and 4) the
methods used to distribute their products or provide their services. The Company believes each of its regions meet these
criteria as each provides similar services and products to similar customers using similar methods of productions and similar
methods to distribute the services and products.
Because we believe we meet each of the criteria set forth above and each of our regions have similar economic
characteristics, we aggregate our results of operations in one reportable operating segment, managed care.
Seasonality
While we are not directly impacted by seasonal shifts, we are affected by the change in working days in a given
quarter. There are generally fewer working days for our employees to generate revenue in the third fiscal quarter as we
experience vacations, inclement weather and holidays.
Summary of Fiscal 2015 Annual Results
The Company had record revenues of $493 million for fiscal year ended March 31, 2015, an increase of $14 million, or
2.9%, compared to $479 million for fiscal year ended March 31, 2014. The increase was primarily due to growth in the TPA
services offset by a decrease in network solutions services.
During fiscal 2015, the Company’s gross profit decreased to $100.0 million from $108.5 million in fiscal 2014. This
decrease was primarily due to a decrease in higher margin network solutions services and an increase in lower margin
TPA services.
During fiscal 2015, the Company’s days sales outstanding (“DSO”) remained consistent with fiscal 2014 at 43 days.
We expect DSO to remain in the low to mid 40-day range.
During fiscal 2015, the Company’s general and administrative expenses increased to $54.4 million from $52.0 million
in fiscal 2014. The increase is primarily due to IT expenses related to bringing a new data center online to increase
system capacity.
During fiscal 2015, the Company also continued to repurchase shares of its common stock under a plan originally
approved by the Company’s Board of Directors in 1996. In August 2013, the Company’s Board of Directors increased the
number of shares authorized to be repurchased over the life of the plan to 34,000,000 shares. During fiscal 2015, the
Company spent $31.8 million to repurchase 845,014 shares of its common stock. Since commencing this program in the fall
of 1996, the Company has repurchased 32,992,488 shares of its common stock through March 31, 2015, at a cost of $360
million. These repurchases were funded primarily from the Company’s operating cash flows.
32
Results of Operations
The Company derives its revenues from providing patient management and network solutions services to payors of
workers’ compensation benefits, auto insurance claims and health insurance benefits. Patient management services include
utilization review, medical case management, vocational rehabilitation, and claims processing. Network solutions revenues
include fee schedule auditing, hospital bill auditing, independent medical examinations, diagnostic imaging review services
and preferred provider referral services. The percentages of total revenues attributable to patient management and network
solutions services for the fiscal years ended March 31, 2013, 2014, and 2015 are listed below.
2013
2014
2015
Patient management services ......................................................................................................................................................................................
Network solutions services .........................................................................................................................................................................................
51.5%
48.5%
51.9%
48.1%
54.5%
45.5%
100.0%
100.0%
100.0%
As noted in the table above, from fiscal 2013 to fiscal 2015, the mix of the Company’s revenues moved 3.0 percentage
points from network solutions to patient management. This mix shift is primarily due to the Company’s increased focus in the
sale of TPA services which are included with patient management services. The Company expects to have more growth in
the sale of TPA services than its other services because we are focusing more of our efforts in this area because there are
more opportunities for growth in revenue and gross profits.
The following table shows the consolidated income statements for the past three fiscal years and the dollar changes as
well as the percentage changes for each fiscal year in thousands, except for per share information.
Fiscal
2013
Fiscal
2014
Fiscal
2015
Amount
Change from
Fiscal 2013 to
2014
Amount
Change from
Fiscal 2014
to 2015
Percent
Change from
Fiscal 2013
to 2014
Percent
Change from
Fiscal 2014
to 2015
Revenues .....................................................................................................................................................................................................................
Cost of revenues .........................................................................................................................................................................................................
49,506 $
32,685
$ 492,625
392,656
$ 478,816
370,335
$ 429,310
337,650
13,809
22,321
11.5%
9.7
2.9%
6.0
$
Gross profit .................................................................................................................................................................................................................
General and
99,969
108,481
91,660
16,821
(8,512)
18.4
(7.8)
administrative .........................................................................................................................................................................................................
54,405
51,974
47,765
4,209
2,431
8.8
4.7
Income before income
taxes .......................................................................................................................................................................................................................
Income tax provision ..................................................................................................................................................................................................
45,564
16,974
56,507
22,115
43,895
17,165
(10,943)
(5,141)
12,612
4,950
(19.4)
(23.2)
28.7
28.8
Net income ..................................................................................................................................................................................................................
$ 28,590
$ 34,392
$ 26,730
(16.9%)
5,802)
28.7%
7,662
$
($
Net income per share:
Basic ..................................................................................................................................................................................................................
Diluted ...............................................................................................................................................................................................................
0.43 $
0.42 $
(15.3%)
(14.9%)
35.8%
35.3%
(0.25)
(0.24)
1.20
1.19
1.63
1.61
1.38
1.37
$
$
$
$
$
$
$
$
Shares used in net income
per share:
Basic ..................................................................................................................................................................................................................
Diluted ...............................................................................................................................................................................................................
20,669
20,890
21,104
21,372
22,256
22,458
(5.2%)
(4.8%)
(1,152)
(1,086)
(2.1%)
(2.3%)
(435)
(482)
As previously identified in the section titled “Risk Factors” in this report, the Company’s ability to maintain or grow
revenues is subject to several risks including, but not limited to, changes in government regulations, exposure to litigation
and the ability to add or retain customers. Any of these, or a combination of all of them, could have a material and adverse
effect on the Company’s results of operations going forward.
33
The following table sets forth, for the periods indicated, the percentage of revenues represented by certain items
reflected in the Company’s consolidated statements of income. The Company’s past operating results are not necessarily
indicative of future operating results. The percentages for the three fiscal years ended March 31, 2013, 2014 and 2015
are as follows:
2013
2014
2015
Revenues .....................................................................................................................................................................................................................
Cost of revenues .........................................................................................................................................................................................................
100.0%
79.7%
100.0%
78.6%
100.0%
77.3%
Gross profit .................................................................................................................................................................................................................
General and administrative .........................................................................................................................................................................................
20.3%
11.0%
22.7%
10.9%
21.4%
11.1%
Income before income taxes .......................................................................................................................................................................................
Income tax provision ..................................................................................................................................................................................................
10.3%
4.1%
11.8%
4.6%
9.3%
3.4%
Net Income .................................................................................................................................................................................................................
7.2%
6.2%
5.9%
Revenue
The Company derives its revenues from providing patient management and network solutions services to payors of
workers’ compensation benefits, auto insurance claims and health insurance benefits. Patient management services include
claims administration, utilization review, medical case management and vocational rehabilitation. Network solutions
revenues include fee schedule auditing, hospital bill auditing, independent medical examinations, diagnostic imaging review
services, directed care services and preferred provider referral services.
Change in Revenue
Fiscal 2015 Compared to Fiscal 2014
Revenues increased by 2.9%, to $493 million in fiscal 2015, from $479 million in fiscal 2014, an increase of $14
million. The increase was primarily due to growth in the TPA services within patient management due to an increase in
customers. Patient management revenues, which include TPA services, increased by $21 million, or 8.5%, from $248 million
in fiscal 2014 to $269 million in fiscal 2015. This increase in revenues from TPA services was due to a 5% increase in the
number of customers, an 11% increase in the total number of claims opened during the fiscal year. Network solutions
services revenues decreased by $6.0 million, or 2.6%, from $230 million in fiscal 2014 to $224 million in fiscal 2015, due to
a 5% decrease in the number of bills processed slightly offset by a 2% increase in the revenue per bill.
Fiscal 2014 Compared to Fiscal 2013
Revenues increased by 11.5%, to $479 million in fiscal 2014, from $429 million in fiscal 2013, an increase of $50
million. The increase was primarily due to growth in the TPA services within patient management due to an increase in
customers and pharmacy services. Patient management revenues, which include TPA services, increased by $26 million, or
11.7%, from $222 million in fiscal 2013 to $248 million in fiscal 2014. This increase in revenues from TPA services was due
to a 10% increase in the number of customers, a 33% increase in the total number of claims opened during the fiscal year and
a 9% decrease in the average revenue per claim. Network solutions services revenues increased by $22 million, or 10.6%,
from $208 million in fiscal 2013 to $230 million in fiscal 2014, due to a 5% increase in the number of bills processed and the
revenue per bill is comparable to prior year.
Cost of Revenue
The Company’s cost of revenues consist of direct expenses, costs directly attributable to the generation of revenue, and
field indirect costs which are incurred in the field to support the operations in the field offices which generate the revenue.
Direct costs are primarily case manager salaries, bill review analysts, related payroll taxes and fringe benefits, and costs for
Independent Medical Examinations (IME), prescription drugs, and MRI providers. Most of the Company’s revenues are
generated in offices which provide both patient management services and network solutions services. The largest of the field
indirect costs are manager salaries and bonus, account executive base pay and commissions, administrative and clerical
support, field systems personnel, PPO network developers, related payroll taxes, fringe benefits, office rent, and telephone
expense. During fiscal 2014 and 2015, approximately 35% of the costs incurred in the field are field indirect costs which
support both the patient management services and network solutions operations of the Company’s field operations.
34
Change in Cost of Revenue
Fiscal 2015 Compared to Fiscal 2014
The Company’s cost of revenues increased from $370 million in fiscal 2014 to $393 million in fiscal 2015, an increase
of 6.0%, or $22 million. The increase in cost of revenues is primarily due to the 2.9% increase in revenues noted above. The
cost of revenues increased at a higher rate than revenue due to an increase in lower margin patient management TPA services
and a decrease in higher margin bill review services. Pharmacy costs increased from $59 million to $61 million due to an
increase in revenue in this line of business. Additionally, headcount increased which is reflected in our direct labor costs that
increased from $99 million to $107 million due to increased services to TPA customers.
Fiscal 2014 Compared to Fiscal 2013
The Company’s cost of revenues increased from $338 million in fiscal 2013 to $370 million in fiscal 2014, an increase
of 9.7%, or $33 million. The Company had record revenues in fiscal 2014, and gross profit increased $16.8 million from
fiscal 2013 to fiscal 2014. The increase in cost of revenues is primarily due to the 12% increase in revenues noted above.
Pharmacy costs increased from $51 million to $59 million due to an increase in revenue in this line of business. Additionally,
headcount increased which is reflected in our direct labor costs that increased from $92 million to $99 million due to
increased services to TPA customers. During the past two fiscal years, the Company’s gross margin increased
from 21% to 23%.
General and Administrative Expense
During fiscal years 2013, 2014 and 2015, approximately 60%, 59%, and 61% respectively, of general and
administrative costs consisted of corporate systems costs, which include the corporate systems support, implementation and
training, rules engine development, national information technology (IT) strategy and planning, depreciation of the hardware
costs in the Company’s corporate offices and backup data center, the Company’s national wide area network, and other
systems related costs. The Company includes all IT related costs managed by the corporate office in general and
administrative whereas the field IT related costs are included in the cost of revenues. The remaining general and
administrative costs consist of national marketing, national sales support, corporate legal, corporate insurance, human
resources, accounting, product management, new business development, and other general corporate expenses.
Change in General and Administrative Expense
Fiscal 2015 Compared to Fiscal 2014
General and administrative expense increased 4.7% from $52 million in fiscal 2014 to $54.4 million in fiscal 2015. In
fiscal 2015, the Company increased IT expenses related to a new data center being brought online to increase system
capacity. IT expenses increased from $30.7 million in fiscal 2014 to $33 million in fiscal 2015.
The costs associated with the development and maintenance of software products and the implementation and
incorporation of new technologies to remain competitive could have a material adverse effect on the Company’s results of
operations in the future. Likewise, the Company’s exposure to litigation and increasing costs of insurance could have a
material adverse effect on the Company’s results of operations as well.
Fiscal 2014 Compared to Fiscal 2013
General and administrative expense increased 8.8% from $47.8 million in fiscal 2013 to $52 million in fiscal 2014. In
fiscal 2014, the Company increased IT expenses related to a new data center being brought online to increase system
capacity. IT expenses increased from $28.8 million in fiscal 2013 to $30.7 million in fiscal 2014. Additionally, stock
compensation expense increased from $0.5 million to $1.5 million due to the Company achieving the targets on certain
performance stock options.
35
Income Tax Provision
Fiscal 2015 Compared to Fiscal 2014
The Company’s income tax expense was $22 million for fiscal year 2014 and $17 million for fiscal year 2015. The
income tax expense was calculated based on a 39% tax rate for fiscal year 2014 and 37.3% for fiscal year 2015. The decrease
of $5 million was primarily due to a decrease in income before income taxes. Additionally, the rate decreased during fiscal
year 2015 due to review of the state tax filings and the Company’s apportionment. The Company expects the rate to
normalize in the next fiscal year. The income tax provision rates were based upon management’s review of the Company’s
estimated annual income tax rate, including state taxes. This effective tax rate differed from the statutory federal tax rate of
35.0% primarily due to state income taxes and certain non-deductible expenses offset by tax credits.
Fiscal 2014 Compared to Fiscal 2013
The Company’s income tax expense was $17 million for fiscal year 2013 and $22 million for fiscal year 2014. The
income tax expense was calculated based on a 39% tax rate that was consistent for both fiscal years and the increase of $5
million was primarily due to an increase in income before income taxes.
Net Income
Fiscal 2015 Compared to Fiscal 2014
The Company’s net income for fiscal years 2014 and 2015 was $34.4 million and $28.6 million, respectively. The
Company’s net income in fiscal 2015 decreased due to a decrease in gross profit margin due to an increase in lower margin
TPA business.
Fiscal 2014 Compared to Fiscal 2013
The Company’s net income for fiscal years 2013 and 2014 was $26.7 million and $34.4 million, respectively. The
Company’s net income in fiscal 2014 increased due to an increase in revenue and gross profit margin. Additionally, the
Company experienced a decrease in general and administrative costs as a percentage of revenue.
Earnings per Share
Fiscal 2015 Compared to Fiscal 2014
The Company’s diluted earnings per share for fiscal years 2014 and 2015 were $1.61 and $1.37, respectively. The
Company’s earnings per share in fiscal 2015 decreased due to a decrease in net income of $5.8 million.
Fiscal 2014 Compared to Fiscal 2013
The Company’s diluted earnings per share for fiscal years 2013 and 2014 were $1.19 and $1.61, respectively. The
Company’s earnings per share in fiscal 2014 increased due to a reduction in shares outstanding because of the shares
repurchased in the Company’s share repurchase program which reduced weighted shares. Additionally, the Company had an
increase in net income of $7.7 million.
Liquidity and Capital Resources
Introduction
The Company manages its liquidity and financial position in the context of its overall business strategy. The Company
continually forecasts and manages its cash, investments, working capital balances and capital structure to meet the short- and
long-term obligations of its businesses while seeking to maintain liquidity and financial flexibility. Cash flows generated
from operating activities are principally from earnings before non-cash expenses. The risk of decreased operating cash flow
from a decline in earnings is partially mitigated by the diversity of the Company’s services, geographies and customers, and
the Company’s lack of any interest-bearing debt for the past 24 years.
36
The Company has historically funded its operations and capital expenditures primarily from cash flow from operations,
and to a lesser extent, stock option exercises. The Company’s net accounts receivables have averaged below 43 days of
average sales for the past two fiscal years and were at 43 days at March 31, 2015. Property, net of accumulated depreciation,
has historically averaged approximately 11% or less of annual revenue. The Company’s historical profit margins and
historical ratio of investments in assets used in the business has allowed the Company to generate sufficient cash flow to
repurchase $360 million of its common stock during the past eighteen fiscal years, on inception-to-date net earnings of $365
million. The Company repurchases shares during periods of excess liquidity which has occurred in all 24 years the Company
has been public. Should the Company have lower income or cash flows, it could reduce or eliminate the share repurchase
program until earnings and cash flow improves. Working capital decreased from $49 million to $45 million from March 31,
2014 to March 31, 2015 because of a decrease in cash.
The Company believes that cash from operations and funds from exercises of stock options granted to employees are
adequate to fund existing obligations, repurchase shares of the Company’s common stock under its current share repurchase
program, introduce new services, and continue to develop healthcare related businesses for at least the next twelve months.
The Company regularly evaluates cash requirements for current operations, commitments, and for capital acquisitions and
other strategic transactions. The Company may elect to raise additional funds for these purposes, through debt or equity
financings or otherwise, as appropriate. Additional equity or debt financing may not be available when needed, on terms
favorable to us or at all.
As of March 31, 2015, the Company had $26 million in cash and cash equivalents, invested primarily in short-term,
interest-bearing highly liquid investment-grade securities with maturities of 90 days or less.
In September 2014, the Company renewed a line of credit agreement. The line is with a financial institution to provide
a revolving credit facility with borrowing capacity of up to $10 million. Borrowings under this agreement, as amended, bear
interest, at the Company’s option, at a fixed LIBOR-based rate plus 1.50% or at a fluctuating rate determined by the financial
institution to be 1.50% above the daily one-month LIBOR rate. The loan covenants require the Company to maintain the
current assets to liabilities ratio of at least 1.25:1, debt to tangible net worth not greater than 1.25:1 and have positive net
income. The Company’s management believes it was in compliance with all of its loan covenants as of March 31, 2015. As
of March 31, 2015, the Company had borrowed on the line of credit in the amount of $618,000, which was included in
accrued liabilities on the balance sheet and was paid off on April 1, 2015. Letters of credit in the aggregate amount of $4.5
million have been issued separate from the line of credit and therefore do not reduce the amount of borrowings available
under the revolving credit facility. The credit agreement expires in September 2015.
The Company believes that the cash balance at March 31, 2015 along with anticipated internally generated funds, and
the credit facility would be sufficient to meet the Company’s expected cash requirements for at least the next twelve months.
Operating Cash Flows
Fiscal 2015 Compared to Fiscal 2014
Net cash provided by operating activities was $55 million in fiscal 2014 and $44 million in fiscal 2015. While net
income decreased by $5.8 million, along with a decrease in accounts and taxes payable due to a decrease in the tax rate,
which was partially offset by an increase in accounts receivable.
Fiscal 2014 Compared to Fiscal 2013
Net cash provided by operating activities was $55 million in fiscal 2013 and fiscal 2014. While net income increased
by $7.7 million, it was offset by an increase in accounts receivable due to a growth in revenue and a small increase to DSO.
Investing Activities
Fiscal 2015 Compared to Fiscal 2014
Net cash flow used in investing activities increased from $18 million in fiscal 2014 to $24 million in fiscal 2015. The
increase in cash flow used in investing activities was due to an increase in property additions in leasehold improvements and
an increase in the amount spent on capitalized hardware related to a new data center being built out to increase our
system capacity.
37
Fiscal 2014 Compared to Fiscal 2013
Net cash flow used in investing activities increased from $15 million in fiscal 2013 to $18 million in fiscal 2014. The
increase in cash flow used in investing activities was primarily due to an increase in property additions. The property increase
is due to an increase in the amount spent on capitalized hardware related to a new data center being built out to increase our
system capacity. The Company expects future expenditures for property and equipment to increase if revenues increase.
Financing Activities
Fiscal 2015 Compared to Fiscal 2014
Net cash flow used in financing activities increased from $21.4 million in fiscal 2014 to $29.4 million in fiscal 2015.
The increase in cash flow used in financing activities was due to an increase in the purchase of common stock under the
Company’s share repurchase program. During fiscal 2015, the Company spent $31.8 million to repurchase 845,014 shares of
its common stock (at an average price of $37.63 per share). During fiscal 2014, the Company spent $27.2 million to
repurchase 830,460 shares of its common stock (at an average price of $32.73 per share).
If the Company continues to generate cash flow from operating activities, the Company may continue to repurchase
shares of its common stock on the open market, if authorized by the Company’s Board of Directors, or seek to identify other
businesses to acquire. In August 2013, the Board of Directors increased the number of shares authorized to be repurchased
over the life of the stock repurchase program by an additional 2,000,000 shares to 34,000,000 shares. The Company has
historically used cash provided by operating activities and from the exercise of stock options to repurchase stock. The
Company expects that it may use some of the cash on the balance sheet at March 31, 2015 to repurchase additional shares of
its common stock in the future.
Fiscal 2014 Compared to Fiscal 2013
Net cash flow used in financing activities decreased from $27 million in fiscal 2013 to $21 million in fiscal 2014. The
decrease in cash flow used in financing activities was due to a decrease in the purchase of common stock under the
Company’s share repurchase program. During fiscal 2014, the Company spent $27.2 million to repurchase 830,460 shares of
its common stock (at an average price of $32.73 per share). During fiscal 2013, the Company spent $31 million to repurchase
1,410,812 shares of its common stock (at an average price of $21.78 per share). The change noted above was partially offset
by an increase in cash received from tax benefits related to option exercises which increased from $0.3 million to $2 million.
This was due to a higher share price of options exercised.
Contractual Obligations
The following table set forth our contractual obligations at March 31, 2015, which are primarily future minimum lease
payments due under non-cancelable operating leases:
Total
Less than one year
1-3 Years
3-5 Years
More than 5 Years
For the Fiscal Years Ended March 31:
Operating leases ...............................................................................................................................................
Uncertain tax positions ....................................................................................................................................
Software license ...............................................................................................................................................
Investment in private equity ............................................................................................................................
$51,530,000
2,129,000
1,172,000
600,000
$22,460,000
—
—
—
15,324,000
2,129,000
1,172,000
600,000
$8,610,000
—
—
—
$
Total .................................................................................................................................................................
$55,431,000
$22,460,000
19,225,000
$8,610,000
$
$
5,136,000
—
—
—
$
5,136,000
Litigation. The Company is involved in litigation arising in the normal course of business. Management believes that
resolution of these matters will not result in any payment that, in the aggregate, would be material to the financial position or
results of the operations of the Company.
Inflation. The Company experiences pricing pressures in the form of competitive prices. The Company is also
impacted by rising costs for certain inflation-sensitive operating expenses such as labor and employee benefits, and facility
leases. However, the Company generally does not believe these impacts are material to its revenues or net income.
38
Off-Balance Sheet Arrangements
The Company is not a party to off-balance sheet arrangements as defined by the Securities and Exchange Commission.
However, from time to time the Company enters into certain types of contracts that contingently require the Company to
indemnify parties against third-party claims. The contracts primarily relate to: (i) certain contracts to perform services, under
which the Company may provide customary indemnification to the purchases of such services; (ii) certain real estate leases,
under which the Company may be required to indemnify property owners for environmental and other liabilities, and other
claims arising from the Company’s use of the applicable premises; and (iii) certain agreements with the Company’s officers,
directors and employees, under which the Company may be required to indemnify such persons for liabilities arising out of
their relationship with the Company.
The terms of such obligations vary by contract and in most instances a specific or maximum dollar amount is not
explicitly stated therein. Generally, amounts under these contracts cannot be reasonably estimated until a specific claim is
asserted. Consequently, no liabilities have been recorded for these obligations on the Company’s balance sheets for any of the
periods presented.
Critical Accounting Policies
The SEC defines critical accounting policies as those that require application of management’s most difficult,
subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are
inherently uncertain and may change in subsequent periods.
The following is not intended to be a comprehensive list of our accounting policies. Our significant accounting policies
are more fully described in Note A to the Consolidated Financial Statements. In many cases, the accounting treatment of a
particular transaction is specifically dictated by accounting principles generally accepted in the United States of America,
with no need for management’s judgment in their application. There are also areas in which management’s judgment in
selecting an available alternative would not produce a materially different result.
We have identified the following accounting policies as critical to us: 1) revenue recognition, 2) allowance for
uncollectible accounts, 3) goodwill and long-lived assets, 4) accrual for self-insured costs, 5) accounting for income taxes, 6)
legal and other contingencies, 7) share-based compensation, and 8) software development costs.
Revenue Recognition: The Company recognizes revenue when there is persuasive evidence of an arrangement, the
services have been provided to the customer, the sales price is fixed or determinable, and collectability is reasonably
assured. For the Company’s services, as the Company’s professional staff performs work, they are contractually permitted to
bill for fees earned in fraction of an hour increments worked or by units of production. The Company recognizes revenue as
the time is worked or as units of production are completed, which is when the revenue is earned and realized. Labor costs are
recognized as the costs are incurred. The Company derives the majority of its revenue from the sale of Network Solutions
and Patient Management services. Network Solutions and Patient Management services may be sold individually or
combined with any of the services the Company provides. When a sale combines multiple elements, the Company accounts
for multiple element arrangements in accordance with the guidance included in Accounting Standard Codification
(“ASC”) 605-25.
Management evaluates agreements with customers in accordance with the provision of the revenue recognition topic
that addresses multiple-deliverable revenue arrangements. The multiple-deliverable arrangements entered into consist of
bundled managed care which included various units of accounting such as network solutions, and patient management which
includes claims administration. Such elements are considered separate units of accounting due to each element having value
to the customer on a stand-alone basis. The selling price for each unit of accounting is determined using contract price and
management estimates. When the Company’s customers purchase several products, the pricing of the products sold is
generally the same as if the product were sold on an individual basis. Revenue is recognized as the work is performed in
accordance with our customer contracts. Based upon the nature of the Company’s products, bundled managed care elements
are generally delivered in the same accounting period. The Company recognizes revenue for patient management claims
administration services over the life of the customer contract. Based upon prior experience in managing claims, the Company
estimates the deferral amount from when the claim is received to when the customer contract expires.
Allowance for Uncollectible Accounts: The Company determines its allowance by considering a number of factors,
including the length of time trade accounts receivable are past due, the Company’s previous loss history, the customers’
current ability to pay its obligation to the Company, and the condition of the general economy and the industry as a whole.
The Company writes off accounts receivable when they become uncollectible.
39
The Company must make significant management judgments and estimates in determining contractual and bad debt
allowances in any accounting period. One significant uncertainty inherent in the Company’s analysis is whether its past
experience will be indicative of future periods. Although the Company considers future projections when estimating
contractual and bad debt allowances, the Company ultimately makes its decisions based on the best information available to
it at that time. Adverse changes in general economic conditions or trends in reimbursement amounts for the Company’s
services could affect the Company’s contractual and bad debt allowance estimates, collection of accounts receivable, cash
flows, and results of operations. No one customer accounted for 10% or more of accounts receivable at March 31, 2014,
and 2015.
Goodwill and Long-Lived Assets: Goodwill arising from business combinations represents the excess of the purchase
price over the estimated fair value of the net assets of the acquired business. Pursuant to ASC 350-10 through ASC 350-30,
“Goodwill and Other Intangible Assets,” goodwill is tested annually for impairment or more frequently if circumstances
indicate the potential for impairment. Also, management tests for impairment of its amortizable intangible assets and long-
lived assets annually and whenever events or changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. The Company’s impairment analysis is conducted at a regional level. The measurement of fair value is based
on an evaluation of market capitalization and is further tested using a multiple of earnings approach. In projecting the
Company’s cash flows, management considers industry growth rates and trends and cost structure changes. Based on the
Company’s tests and reviews, no impairment of its goodwill, intangible assets or other long-lived assets existed at March 31,
2015. However, future events or changes in current circumstances could affect the recoverability of the carrying value of
goodwill and long-lived assets. Should an asset be deemed impaired, an impairment loss would be recognized to the extent
the carrying value of the asset exceeded its estimated fair market value.
Accrual for Self-insurance Costs: The Company accrues for the group medical costs and workers’ compensation costs
of its employees based on claims filed and an estimate of claims incurred but not reported as of each balance sheet date. The
Company purchases stop loss insurance for large claims. The Company determines its estimated self-insurance reserves
based upon historical trends along with outstanding claims information provided by its claims paying agents. However, it is
possible that recorded accruals may not be adequate to cover the future payment of claims. Adjustments, if any, to estimated
accruals resulting from ultimate claim payments will be reflected in earnings during the periods in which such adjustments
are determined. The Company’s self-insured liabilities contain uncertainties because management is required to make
assumptions and to apply judgment to estimate the ultimate cost to settle reported claims and claims incurred but not reported
at the balance sheet date.
The Company does not believe there is a reasonable likelihood that there will be a material change in the estimates or
assumptions used to calculate its self-insured liabilities. However, if actual results are not consistent with these estimates or
assumptions, the Company may be exposed to losses or gains that could be material.
Accounting for Income Taxes: The Company records a tax provision for the anticipated tax consequences of the
reported results of operations. The provision for income taxes is computed using the asset and liability method, under which
deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between
the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred
tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years
in which those tax assets are expected to be realized or settled. The Company records a valuation allowance, if necessary, to
reduce deferred tax assets to the amount that is believed more likely than not to be realized.
The Company recognizes tax benefits from uncertain tax positions only if it is more likely than not that the tax position
will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits
recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater
than 50% likelihood of being realized upon ultimate settlement.
Management believes it is more likely than not that forecasted income, including income that may be generated as a
result of certain tax planning strategies, together with future reversals of existing taxable temporary differences, will be
sufficient to fully recover the deferred tax assets. In the event that the Company determines all or part of the net deferred tax
assets are not realizable in the future, the Company will make an adjustment to the valuation allowance that would be charged
to earnings in the period such determination is made. In addition, the calculation of tax liabilities involves significant
judgment in estimating the impact of uncertainties in the application of accounting principles generally accepted in the
United States of America and complex tax laws. Resolution of these uncertainties in a manner inconsistent with
management’s expectations could have a material impact on the Company’s financial condition and operating results. The
significant assumptions and estimates described above are important contributors to our ultimate effective tax rate in
each year.
40
Legal and Other Contingencies: As discussed in Part I, Item 3 of this Form 10-K under the heading “Legal
Proceedings” and in Note I, “Contingencies and Legal Proceedings” in Notes to Consolidated Financial Statements, the
Company is subject to various legal proceedings and claims that arise in the ordinary course of business. The Company
records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. There is
significant judgment required in both the probability determination and as to whether an exposure can be reasonably
estimated. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a
material loss, or a material loss in excess of a recorded accrual, with respect to loss contingencies. However, the outcome of
legal proceedings and claims brought against the Company are subject to significant uncertainty.
Share-Based Compensation: The Company accounts for share-based compensation in accordance with the provisions
of ASC Topic 718 “Compensation — Stock Compensation”. Under ASC 718, share-based compensation cost is measured at
the grant date, based on the calculated fair value of the award, and is recognized as an expense over the employee’s requisite
service period (generally the vesting period of the equity grant). For the fiscal year ended March 31, 2015, the Company
recorded share-based compensation expense of $2,209,000. Share-based compensation expense recognized in fiscal 2015 is
based on awards ultimately expected to vest; therefore, it has been reduced for estimated forfeitures. ASC Topic 718 requires
forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from
those estimates.
The Company estimates the fair value of stock options using the Black-Scholes valuation model. Key input
assumptions used to estimate the fair value of stock options include the exercise price of the award, the expected option term,
the expected volatility of the Company’s stock over the option’s expected term, the risk-free interest rate over the option’s
term, and the Company’s expected annual dividend yield. The Company’s management believes that the valuation technique
and the approach utilized to develop the underlying assumptions are appropriate in calculating the fair values of the
Company’s stock options granted in fiscal 2015. Estimates of fair value are not intended to predict actual future events or the
value ultimately realized by persons who receive equity awards.
We do not believe there is a reasonable likelihood there will be a material change in the future estimates or assumptions
we use to determine stock-based compensation expense. However, if actual results are not consistent with our estimates or
assumptions, we may be exposed to changes in stock-based compensation expense that could be material.
Software Development Costs: Development costs incurred in the research and development of new software products
and enhancements to existing software products for internal use are expensed as incurred until technological feasibility has
been established. After technological feasibility is established, any additional external software development costs are
capitalized and amortized on a straight-line basis over the estimated economic life of the related product, which is typically
five years. The Company performs an annual review of the estimated economic life and the recoverability of such capitalized
software costs. If a determination is made that capitalized amounts are not recoverable based on the estimated cash flows to
be generated from the applicable software, any remaining capitalized amounts are written off. Although the Company
believes that its approach to estimates and judgments as described herein is reasonable, actual results could differ and the
Company may be exposed to increases or decreases in revenue that could be material.
Recently Issued Accounting Standards
On May 28, 2014, the FASB issued ASU 2014-09 regarding ASC Topic 606, Revenue from Contracts with Customers.
The standard provides principles for recognizing revenue for the transfer of promised goods or services to customers with the
consideration to which the entity expects to be entitled in exchange for those goods or services. In April 2015, the FASB
issued an exposure draft proposing a one-year delay of the effective date of this new revenue recognition standard. The
guidance will be effective for our fiscal year beginning April 1, 2017. Early adoption is not permitted. We are currently
evaluating the accounting, transition and disclosure requirements of the standard and cannot currently estimate the financial
statement impact of adoption.
41
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of CorVel Corporation
We have audited the accompanying consolidated balance sheets of CorVel Corporation (the “Company”) as of
March 31, 2014 and 2015, and the related consolidated statements of income, stockholders’ equity, and cash flows for each
of the years ended March 31, 2013, 2014 and 2015. In connection with our audits of the consolidated financial statements, we
have also audited the financial statement schedule for each of the years ended March 31, 2013, 2014 and 2015. We also have
audited the Company’s internal control over financial reporting as of March 31, 2015, based on criteria established in the
Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway
Commission (COSO). The Company’s management is responsible for these consolidated financial statements, for
maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control
over financial reporting, included in Management’s Report on Internal Control over Financial Reporting. Our responsibility
is to express an opinion on these consolidated financial statements and an opinion on the Company’s internal control over
financial reporting based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United
States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the
consolidated financial statements are free of material misstatement and whether effective internal control over financial
reporting was maintained in all material respects. Our audits of the consolidated financial statements included examining, on
a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the
accounting principles used and significant estimates made by management, and evaluating the overall financial statement
presentation. Our audit of internal control over financial reporting included obtaining an understanding of internal control
over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and
operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other
procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for
our opinion.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
accounting principles generally accepted in the United States of America. A company’s internal control over financial
reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance
that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting
principles generally accepted in the United States of America, and that receipts and expenditures of the company are being
made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets
that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures
may deteriorate.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the
consolidated financial position of the Company as of March 31, 2014 and 2015, and the consolidated results of its operations
and its cash flows for each of the years ended March 31, 2013, 2014 and 2015, in conformity with accounting principles
generally accepted in the United States of America. Also, in our opinion, the financial statement schedule for each of the
years ended March 31, 2013, 2014 and 2015, when considered in relation to the basic consolidated financial statements taken
as a whole, presents fairly, in all material respects, the information set forth therein. Also, in our opinion, the Company
maintained, in all material respects, effective internal control over financial reporting as of March 31, 2015, based on criteria
established in the Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of
the Treadway Commission (COSO).
/s/ HASKELL & WHITE LLP
Irvine, California
June 11, 2015
42
CORVEL CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
Fiscal Years Ended March 31,
2013
2014
2015
$492,625,000
392,656,000
99,969,000
54,405,000
45,564,000
16,974,000
$ 28,590,000
$
$
1.38
1.37
20,669,000
20,890,000
Revenues ..........................................................................................................................................................
Cost of revenues ..............................................................................................................................................
$429,310,000
337,650,000
$478,816,000
370,335,000
Gross profit ......................................................................................................................................................
General and administrative ..............................................................................................................................
91,660,000
47,765,000
108,481,000
51,974,000
Income before income taxes ............................................................................................................................
Income tax provision .......................................................................................................................................
43,895,000
17,165,000
56,507,000
22,115,000
Net income .......................................................................................................................................................
$ 26,730,000
$ 34,392,000
Net income per share:
Basic ................................................................................................................................................................
1.63
1.20
$
$
Diluted .............................................................................................................................................................
1.61
1.19
$
$
Weighted average shares outstanding:
Basic ................................................................................................................................................................
Diluted .............................................................................................................................................................
22,256,000
22,458,000
21,104,000
21,372,000
See accompanying notes to consolidated financial statements.
43
CORVEL CORPORATION
CONSOLIDATED BALANCE SHEETS
March 31,
2014
2015
ASSETS
Current Assets ..................................................................................................................................................
Cash and cash equivalents ...............................................................................................................................
Customer deposits ............................................................................................................................................
Accounts receivable (less allowance for doubtful accounts of $1,745,000 at March 31,
$ 34,866,000
16,142,000
2014 and $1,645,000 at March 31, 2015) ...................................................................................................
Prepaid expenses and taxes ..............................................................................................................................
Deferred income taxes .....................................................................................................................................
57,229,000
5,862,000
6,861,000
$ 25,516,000
17,319,000
57,537,000
11,675,000
7,181,000
Total current assets ..........................................................................................................................................
120,960,000
119,228,000
Property and equipment, net ............................................................................................................................
Goodwill ..........................................................................................................................................................
Other intangible assets, net ..............................................................................................................................
Other assets ......................................................................................................................................................
51,253,000
36,814,000
5,193,000
261,000
56,299,000
36,814,000
4,736,000
1,677,000
Total assets.......................................................................................................................................................
$ 214,481,000
$ 218,754,000
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities ............................................................................................................................................
Accounts and taxes payable .............................................................................................................................
Accrued liabilities ............................................................................................................................................
$ 18,465,000
53,375,000
$ 15,770,000
58,318,000
Total current liabilities .....................................................................................................................................
Deferred income taxes .....................................................................................................................................
71,840,000
16,119,000
74,088,000
16,743,000
Total liabilities .................................................................................................................................................
87,959,000
90,831,000
Commitments and contingencies (Notes E, F, H, I, J and L)
Stockholders’ Equity
Common stock, $.0001 par value: 120,000,000 shares authorized at March 31, 2014
and 2015; 53,126,866 shares issued (20,979,392 shares outstanding, net of
Treasury shares) and 53,243,157 shares issued (20,250,669 shares outstanding, net
of Treasury shares) at March 31, 2014 and March 31, 2015, respectively ..................................................
3,000
Paid-in-capital ..................................................................................................................................................
Treasury Stock, at cost (32,147,474 and 32,992,488 shares at March 31, 2014 and
118,831,000
3,000
123,440,000
(328,480,000)
2015, respectively) ......................................................................................................................................
Retained earnings .............................................................................................................................................
336,168,000
(360,278,000)
364,758,000
Total stockholders’ equity ...............................................................................................................................
126,522,000
127,923,000
$ 214,481,000
$ 218,754,000
See accompanying notes to consolidated financial statements.
44
CORVEL CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
Fiscal Years Ended March 31, 2013, 2014 and 2015
Common
Shares
Stock
Amount
Paid-in-Capital
Treasury Shares
Treasury
Stock
Retained Earnings
Balance – March 31,
2012 .......................................................................................................................................................................................
52,523,748 $ 3,000 $ 105,907,000
$(270,574,000)
$ 275,046,000
(29,906,202)
Stock issued under
employee stock
purchase plan ..........................................................................................................................................................................
313,000
—
14,056
—
—
—
Stock issued under stock
option plan, net of
3,399,000
shares repurchased ..................................................................................................................................................................
299,458
—
—
—
—
Stock-based
compensation
expense ...................................................................................................................................................................................
997,000
—
—
—
—
—
Income tax benefits from
stock option
exercises..................................................................................................................................................................................
308,000
—
—
—
—
—
Purchase of treasury
stock........................................................................................................................................................................................
Net income ...................................................................................................................................................................................
(30,727,000)
—
(1,410,812)
—
—
—
—
26,730,000
—
—
—
—
Balance – March 31,
2013 ........................................................................................................................................................................................
(301,301,000)
110,924,000
(31,317,014)
52,837,262
301,776,000
3,000
Stock issued under
employee stock
purchase plan ..........................................................................................................................................................................
346,000
—
8,489
—
—
—
Stock issued under stock
option plan, net of
3,386,000
shares repurchased ..................................................................................................................................................................
281,115
—
—
—
—
Stock-based
compensation
2,140,000
expense ...................................................................................................................................................................................
—
—
—
—
—
Income tax benefits from
stock option
2,035,000
exercises..................................................................................................................................................................................
—
—
—
—
—
Purchase of treasury
stock........................................................................................................................................................................................
Net income ...................................................................................................................................................................................
Balance – March 31,
(27,179,000)
—
(830,460)
—
—
—
—
34,392,000
—
—
—
—
2014 ........................................................................................................................................................................................
(328,480,000)
118,831,000
(32,147,474)
53,126,866
336,168,000
3,000
Stock issued under
employee stock
purchase plan ..........................................................................................................................................................................
400,000
—
12,299
—
—
—
Stock issued under stock
option plan, net of
1,603,000
shares repurchased ..................................................................................................................................................................
103,992
—
—
—
—
Stock-based
compensation
2,209,000
expense ..................................................................................................................................................................................
—
—
—
—
—
Income tax benefits from
stock option
exercises..................................................................................................................................................................................
397,000
—
—
—
—
—
Purchase of treasury
stock ........................................................................................................................................................................................
Net income ...................................................................................................................................................................................
(31,798,000)
—
(845,014)
—
—
—
—
28,590,000
—
—
—
—
Balance – March 31,
2015 ........................................................................................................................................................................................
53,243,157 $ 3,000 $ 123,440,000
$(360,278,000)
$ 364,758,000
(32,992,488)
See accompanying notes to consolidated financial statements.
45
Total
Stockholders’
Equity
$ 110,382,000
313,000
3,399,000
997,000
308,000
(30,727,000)
26,730,000
111,402,000
346,000
3,386,000
2,140,000
2,035,000
(27,179,000)
34,392,000
126,522,000
400,000
1,603,000
2,209,000
397,000
(31,798,000)
28,590,000
$ 127,923,000
CORVEL CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
Fiscal Years Ended March 31,
2013
2014
2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net income .......................................................................................................................................................
$ 34,392,000
Adjustments to reconcile net income to net cash provided by operating
$ 26,730,000
activities:
Depreciation and amortization .........................................................................................................................
16,411,000
Loss on write down or disposal of property or capitalized software................................................................
78,000
Stock-based compensation expense .................................................................................................................
2,140,000
Provision for doubtful accounts .......................................................................................................................
1,332,000
Provision for deferred income taxes ................................................................................................................
(2,519,000)
Changes in operating assets and liabilities:
Accounts receivable .........................................................................................................................................
(9,456,000)
Customer deposits ............................................................................................................................................
(6,035,000)
Prepaid expenses and taxes ..............................................................................................................................
1,556,000
Other assets ......................................................................................................................................................
159,000
Accounts and taxes payable .............................................................................................................................
2,535,000
Accrued liabilities ............................................................................................................................................
14,207,000
(1,894,000)
(4,291,000)
4,845,000
(111,000)
814,000
7,179,000
15,739,000
412,000
997,000
2,123,000
2,276,000
$ 28,590,000
17,995,000
285,000
2,209,000
1,730,000
304,000
(2,038,000)
(1,176,000)
(5,813,000)
(18,000)
(2,695,000)
4,943,000
Net cash provided by operating activities ........................................................................................................
54,800,000
54,819,000
44,316,000
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in private equity ............................................................................................................................
—
Purchases of property and equipment ..............................................................................................................
(18,344,000)
—
(14,887,000)
(1,400,000)
(22,868,000)
Net cash used in investing activities ................................................................................................................
(18,344,000)
(14,887,000)
(24,268,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Exercise of employee stock purchase options ..................................................................................................
346,000
Exercise of common stock options ..................................................................................................................
3,386,000
Tax benefits from stock options .......................................................................................................................
2,035,000
Purchase of treasury stock ...............................................................................................................................
(27,179,000)
313,000
3,399,000
308,000
(30,727,000)
400,000
1,603,000
397,000
(31,798,000)
Net cash used in financing activities ................................................................................................................
(21,412,000)
(26,707,000)
(29,398,000)
Net increase (decrease) in cash and cash equivalents ......................................................................................
15,044,000
Cash and cash equivalents at beginning of year ..............................................................................................
19,822,000
13,225,000
6,597,000
(9,350,000)
34,866,000
CASH AND CASH EQUIVALENTS AT END OF YEAR
$ 19,822,000
$ 34,866,000
$ 25,516,000
Supplemental cash flow information
Income taxes paid ............................................................................................................................................
$ 20,791,000
Accrual of software license purchase ..............................................................................................................
$ 2,343,000
Tenant improvement allowance .......................................................................................................................
—
$
$ 9,663,000
—
$
—
$
$ 19,528,000
$
—
$ 3,100,000
See accompanying notes to consolidated financial statements.
46
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note A — Summary of Significant Accounting Policies
Organization: CorVel Corporation (“CorVel” or “the Company”), incorporated in Delaware in 1987, provides services
and programs nationwide that are designed to enable insurance carriers, third party administrators and employers with self-
insured programs to administer, manage and control the cost of workers’ compensation and other healthcare benefits. The
Company provides case management, claims administration, and medical bill review services to these payors.
The Company evaluated all subsequent events or transactions through the date of this filing. During the period
subsequent to March 31, 2015, the Company repurchased 182,113 shares for $6.5 million or an average of $35.89 per share.
These shares were repurchased under the Company’s ongoing share repurchase program described in Note G.
Basis of Presentation: The consolidated financial statements include the accounts of CorVel and its wholly-owned
subsidiaries. Significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates: The preparation of financial statements in compliance with accounting principles generally accepted
in the United States of America requires management to make estimates and assumptions that affect the amounts reported in
the accompanying financial statements. Actual results could differ from those estimates. Significant estimates include the
values assigned to intangible assets, capitalized software development, the allowance for doubtful accounts, accrual for
income taxes, share-based payments related to performance based awards, loss contingencies, estimated claims for claims
administration revenue recognition, estimates used in stock options valuations, and accrual for self-insurance reserves.
Cash and Cash Equivalents: Cash and cash equivalents consist of short-term, interest-bearing highly-liquid investment-
grade securities with maturities of 90 days or less when purchased. The carrying amounts of the Company’s financial
instruments approximate their fair values at March 31, 2014 and 2015 due to the short-term nature of those instruments.
Customer deposits represent cash that is expected to be returned or applied towards payment within one year through our
provider reimbursement services.
Fair Value of Financial Instruments: The Company applies ASC 820, “Fair Value Measurements and Disclosures,”
which defines fair value, establishes a framework for measuring fair value, and provides for disclosures about fair value
measurements with respect to fair value measurements of (a) nonfinancial assets and liabilities that are recognized or
disclosed at fair value in the Company’s Consolidated Financial Statements on a recurring basis (at least annually) and (b) all
financial assets and liabilities. ASC 820 prioritizes the inputs used in measuring fair value into the following hierarchy:
Level 1 Quoted market prices in active markets for identical assets or liabilities;
Level 2 Observable inputs other than those included in Level 1 (for example, quoted prices for similar assets in active
markets or quoted prices for identical assets in inactive markets); and
Level 3 Unobservable inputs reflecting management’s own assumptions about the inputs used in estimating the value of
the asset.
The carrying amount of the Company’s financial instruments (i.e. cash, accounts receivable, accounts payable, etc.) are
all Level 1 and approximate their fair values at March 31, 2014 and 2015 due to the short-term nature of those instruments.
The Company has no Level 2 or Level 3 assets.
Investment in Private Equity: During the quarter ended June 30, 2014, the Company’s board of directors approved an
investment of $2,000,000 into a private equity limited partnership that invests in start-up companies. The Company invested
$1,400,000 into the partnership during the fiscal year ended March 31, 2015 and expects to invest the remaining $600,000
commitment within the next 12 months. The Company accounts for the investment on the cost method. The investment is
recorded in other assets on the accompanying consolidated balance sheets. There have been no identified events or changes in
circumstances that may have a significant adverse effect on the fair value of the investment and in accordance with
ASC 825-10-50-16 through 50-19 it is not practicable to estimate the fair value of the investment.
47
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note A — Summary of Significant Accounting Policies (continued)
Revenue Recognition: The Company recognizes revenue when there is persuasive evidence of an arrangement, the
services have been provided to the customer, the sales price is fixed or determinable, and collectability is reasonably
assured. For the Company’s services, as the Company’s professional staff performs work, they are contractually permitted to
bill for fees earned in fraction of an hour increments worked or by units of production. The Company recognizes revenue as
the time is worked or as units of production are completed, which is when the revenue is earned and realized. Labor costs are
recognized as the costs are incurred. The Company derives the majority of its revenue from the sale of Network Solutions
and Patient Management services. Network Solutions and Patient Management services may be sold individually or
combined with any of the services the Company provides. When a sale combines multiple elements, the Company accounts
for multiple element arrangements in accordance with the guidance included in ASC 605-25.
Management evaluates agreements with customers in accordance with the provision of the revenue recognition topic
that addresses multiple-deliverable revenue arrangements. The multiple-deliverable arrangements entered into consist of
bundled managed care which included various units of accounting such as network solutions, and patient management which
includes claims administration. Such elements are considered separate units of accounting due to each element having value
to the customer on a stand-alone basis. The selling price for each unit of accounting is determined using contract price and
management estimates. When the Company’s customers purchase several products the pricing of the products sold is
generally the same as if the product were sold on an individual basis. Revenue is recognized as the work is performed in
accordance with our customer contracts. Based upon the nature of the Company’s products, bundled managed care elements
are generally delivered in the same accounting period. The Company recognizes revenue for patient management claims
administration services over the life of the customer contract. The Company estimates, based upon prior experience in
managing claims, the deferral amount from when the claim is received to when the customer contract expires.
Accounts Receivable: The majority of the Company’s accounts receivable are due from companies in the property and
casualty insurance industries, self-insured employers and governmental entities. Credit is extended based on evaluation of a
customer’s financial condition and, generally, collateral is not required. Accounts receivable are generally due within 30 days
and are stated at amounts due from customers net of an allowance for doubtful accounts. Those accounts outstanding longer
than the contractual payment terms are considered past due. The Company determines its allowance by considering a number
of factors, including the length of time trade accounts receivable are past due, the Company’s previous loss history, the
customer’s current ability to pay its obligation to the Company and the condition of the general economy and the industry as
a whole. The Company writes off accounts receivable against the reserve when they become uncollectible. Accounts
receivable includes $11,922,000, and $12,357,000 of unbilled receivables at March 31, 2014 and 2015, respectively. Unbilled
receivables represent the revenue for the work performed which has not yet been invoiced to the customer. Unbilled
receivables are generally invoiced within the following three months.
Concentrations of Credit Risk: Substantially all of the Company’s customers are payors of workers’ compensation
benefits and property and casualty insurance, which include insurance companies, third party administrators, self-insured
employers and government entities. Receivables are generally due within 30 days. Credit losses relating to customers in the
workers’ compensation insurance industry consistently have been within management’s expectations. Virtually all of the
Company’s cash is invested at financial institutions in amounts which exceed the FDIC insurance levels. No customer
accounted for 10% or more of revenue for either fiscal 2013, 2014, or 2015. No customer accounted for 10% or more of
accounts receivable at either March 31, 2014 or 2015.
Property and Equipment: Additions to property and equipment are recorded at cost. The Company provides for
depreciation on property and equipment using the straight-line method by charges to operations in amounts that allocate the
cost of depreciable assets over their estimated lives as follows:
Asset Classification
Leasehold Improvements
Furniture and Equipment
Computer Hardware
Computer Software
Estimated Useful Life
Five years or the life of lease
Five to seven years
Three to five years
Three to five years
48
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note A — Summary of Significant Accounting Policies (continued)
The Company accounts for internally developed software costs in accordance with ASC 350-40, “Internal – Use
Software”. Capitalized software development costs, intended for internal use, totaled $19,360,000 (net of $53,734,000 in
accumulated amortization) and $21,327,000 (net of $61,012,000 in accumulated amortization), as of March 31, 2014 and
2015, respectively. These costs are included in computer software in property and equipment and are amortized over a period
of five years.
Long-Lived Assets: The carrying amount of all long-lived assets is evaluated periodically to determine if adjustment to
the depreciation and amortization period or to the unamortized balance is warranted. Such evaluation is based principally on
the expected utilization of the long-lived assets and the projected, undiscounted cash flows of the operations in which the
long-lived assets are deployed.
Goodwill and Long-Lived Assets: The Company accounts for its business combinations in accordance with the
Financial Accounting Standards Board (“FASB”) ASC 805-10 through ASC 805-50, “Business Combinations” which
requires that the purchase method of accounting be applied to all business combinations and addresses the criteria for initial
recognition of intangible assets and goodwill. In accordance with FASB ASC 350-10 through ASC 350-30, goodwill and
other intangible assets with indefinite lives are not amortized but are tested for impairment annually, or more frequently if
circumstances indicate the possibility of impairment. If the carrying value of goodwill or an intangible asset exceeds its fair
value, an impairment loss shall be recognized. Based on the Company’s tests and reviews, no impairment of its goodwill,
intangible assets or other long-lived assets existed at March 31, 2015. However, future events or changes in current
circumstances could affect the recoverability of the carrying value of goodwill and long-lived assets. Should an asset be
deemed impaired, an impairment loss would be recognized to the extent the carrying value of the asset exceeded its estimated
fair value. Goodwill amounted to $36,814,000 (net of accumulated amortization of $2,069,000) at March 31, 2014 and at
March 31, 2015.
Cost of revenues: Cost of services consists primarily of the compensation and fringe benefits of field personnel,
including managers, medical bill analysts, field case managers, telephonic case managers, systems support, administrative
support, account managers and account executives, and related facility costs including rent, telephone and office supplies.
Historically, the costs associated with these additional personnel and facilities have been the most significant factor driving
increases in the Company’s cost of services.
Income Taxes: The Company provides for income taxes in accordance with provisions specified in ASC 740,
“Accounting for Income Taxes”. Accordingly, deferred income tax assets and liabilities are computed for differences
between the financial statement and tax bases of assets and liabilities. These differences will result in taxable or deductible
amounts in the future, based on tax laws and rates applicable to the periods in which the differences are expected to affect
taxable income. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income
during the periods in which temporary differences become deductible. In making an assessment regarding the probability of
realizing a benefit from these deductible differences, management considers the Company’s current and past performance,
the market environment in which the Company operates, tax-planning strategies and the length of carry-forward periods for
loss carry-forwards, if any. Valuation allowances are established when necessary to reduce deferred tax assets to amounts that
are more likely than not to be realized. Further, the Company accrues for income tax issues not yet resolved with federal,
state and local tax authorities, when it appears more likely than not that a tax liability has been incurred.
Share-Based Compensation: The Company accounts for share-based compensation in accordance with the provisions
of ASC Topic 718 “Compensation — Stock Compensation”. Under ASC 718, share-based compensation cost is measured at
the grant date, based on the calculated fair value of the award, and is recognized as an expense over the employee’s requisite
service period (generally the vesting period of the equity grant). Share-based compensation expense is based on awards
ultimately expected to vest; therefore, it has been reduced for estimated forfeitures. ASC Topic 718 requires forfeitures to be
estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
49
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note A — Summary of Significant Accounting Policies (continued)
Accrual for Self-insurance Costs: The Company self-insures for the group medical costs and workers’ compensation
costs of its employees. The Company purchases stop loss insurance for large claims. Management believes that the self-
insurance reserves are appropriate; however, actual claims costs may differ from the original estimates requiring adjustments
to the reserves. The Company determines its estimated self-insurance reserves based upon historical trends along with
outstanding claims information provided by its claims paying agents.
Earnings Per Share: Earnings per common share-basic is based on the weighted average number of common shares
outstanding during the period. Earnings per common shares-diluted is based on the weighted average number of common
shares and common share equivalents outstanding during the period. In calculating earnings per share, earnings are the same
for the basic and diluted calculations. Weighted average shares outstanding is greater for diluted earnings per share due to the
effect of stock options.
The difference between the basic shares and the diluted shares for each of the three fiscal years ended March 31, 2013,
2014, and 2015 is as follows:
Fiscal 2013
Fiscal 2014
Fiscal 2015
Basic weighted shares ......................................................................................................................................
22,256,000
Treasury stock impact of stock options ...........................................................................................................
202,000
20,669,000
221,000
21,104,000
268,000
Diluted weighted shares...................................................................................................................................
22,458,000
20,890,000
21,372,000
Stock Split: During the quarter ended June 30, 2013, the Company’s Board of Directors approved a two-for-one stock
split in the form of a 100% stock dividend with a record date of June 12, 2013 and a distribution date of June 26, 2013. All
share and per share amounts have been adjusted retroactively in this report to reflect the stock split for all periods shown.
Recently Issued Accounting Standards
On May 28, 2014, the FASB issued ASU 2014-09 regarding ASC Topic 606, Revenue from Contracts with Customers.
The standard provides principles for recognizing revenue for the transfer of promised goods or services to customers with the
consideration to which the entity expects to be entitled in exchange for those goods or services. In April 2015, the FASB
issued an exposure draft proposing a one-year delay of the effective date of this new revenue recognition standard. The
guidance will be effective for our fiscal year beginning April 1, 2017. Early adoption is not permitted. We are currently
evaluating the accounting, transition and disclosure requirements of the standard and cannot currently estimate the financial
statement impact of adoption.
Note B — Stock Options and Stock-Based Compensation
Under the Company’s Restated Omnibus Incentive Plan (Formerly The Restated 1988 Executive Stock Option Plan)
(“the Plan”) as in effect at March 31, 2015, options for up to 19,365,000 shares of the Company’s common stock may be
granted over the life of the Plan to key employees, non-employee directors and consultants at exercise prices not less than the
fair market value of the stock at the date of grant. Options granted under the Plan are non-statutory stock options and
generally vest 25% one year from date of grant and the remaining 75% vesting ratably each month for the next 36 months.
The options granted to employees and the board of directors expire at the end of five years and ten years from date of
grant, respectively.
The Company records compensation expense for employee stock options based on the estimated fair value of the
options on the date of grant using the Black-Scholes option-pricing model with the assumptions included in the table below.
The Company uses historical data among other factors to estimate the expected volatility, the expected option life, and the
expected forfeiture rate. The risk-free rate is based on the interest rate paid on a U.S. Treasury issue with a term similar to the
estimated life of the option. During fiscal 2015, based upon the historical experience of option cancellations, the Company
has an estimated annualized forfeiture rate of 11.8%. Forfeiture rates will be adjusted over the requisite service period when
actual forfeitures differ, or are expected to differ, from the estimate.
50
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note B — Stock Options and Stock-Based Compensation (continued)
The fair value of each grant is estimated on the date of grant using the Black-Scholes option-pricing model. The
following weighted average assumptions were used for fiscal years ended March 31, 2013, 2014 and 2015:
Fiscal 2013
Fiscal 2014
Fiscal 2015
Expected volatility ...........................................................................................................................................
47%
Risk free interest rate .......................................................................................................................................
0.6% to 0.8%
Dividend yield .................................................................................................................................................
0.0%
Weighted average option life ...........................................................................................................................
4.5 years
45%
1.3% to 1.7%
0.0%
4.4 to 4.5 years
47%
0.7% to 1.5%
0.0%
4.4 to 4.5 years
For the fiscal years ended March 31, 2013, 2014 and 2015, the Company recorded share-based compensation expense
of $997,000, $2,140,000, and $2,209,000, respectively. The table below shows the amounts recognized in the financial
statements for the fiscal years ended March 31, 2013, 2014 and 2015.
Fiscal 2013
Fiscal 2014
Fiscal 2015
Cost of revenue ................................................................................................................................................
General and administrative ..............................................................................................................................
$ 461,000
536,000
$ 672,000
1,468,000
Total cost of stock-based compensation included in income before
income tax .........................................................................................................................................
Amount of income tax benefit recognized .......................................................................................................
997,000
395,000
2,140,000
835,000
Amount charged to net income ........................................................................................................................
$ 602,000
$ 1,305,000
Effect on basic earnings per share ...................................................................................................................
0.03
0.06
$
$
Effect on diluted earnings per share .................................................................................................................
0.03
0.06
$
$
$1,021,000
1,188,000
2,209,000
862,000
$1,347,000
$
$
0.07
0.06
All options granted in the three fiscal years ended March 31, 2013, 2014, and 2015 were granted at fair value and are
non-statutory stock options. Summarized information for all stock options for the past three fiscal years follows:
Fiscal 2013
Fiscal 2014
Fiscal 2015
Options outstanding – beginning of the year ....................................................................................................
Options granted ................................................................................................................................................
Options exercised .............................................................................................................................................
Options cancelled/forfeited ..............................................................................................................................
1,502,046
246,200
(348,090)
(299,204)
1,100,952
441,550
(310,729)
(115,789)
1,115,984
241,625
(111,758)
(82,672)
Options outstanding – end of year ....................................................................................................................
1,100,952
1,115,984
1,163,179
During the year, weighted average exercise price of:
Options granted ................................................................................................................................................
Options exercised .............................................................................................................................................
Options forfeited ..............................................................................................................................................
At the end of the year:
Price range of outstanding options ...................................................................................................................
Weighted average exercise price per share .......................................................................................................
Options available for future grants ...................................................................................................................
Exercisable options...........................................................................................................................................
$ 7.78-$26.38
18.66
$
1,285,056
557,924
$ 7.78-$45.55
24.80
$
959,295
430,294
23.04
12.80
21.26
33.06
15.31
23.33
$ 7.78-$45.55
27.65
$
800,342
559,168
37.64
17.27
32.31
$
$
$
$
$
$
$
$
$
51
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note B — Stock Options and Stock-Based Compensation (continued)
The following table summarizes the status of stock options outstanding and exercisable at March 31, 2015:
Range of Exercise Prices
Number of
Outstanding
Options
Weighted
Average
Remaining
Contractual Life
Outstanding
Options –
Weighted
Average Exercise
Price
Exercisable
Options –
Number of
Exercisable
Options
Exercisable
Options –
Weighted
Average Exercise
Price
$7.78 to $21.87 ................................................................................................................................................
251,199
$21.88 to $23.10 ..............................................................................................................................................
137,145
$23.11 to $34.78 ..............................................................................................................................................
143,601
$34.79 to $45.55 ..............................................................................................................................................
27,223
278,100
261,044
346,323
277,712
15.75
22.94
29.65
41.49
2.91
3.23
3.29
4.26
$
Total .......................................................................................................................................................
559,168
1,163,179
27.65
3.42
$
$
$
15.13
22.94
25.96
43.33
21.20
A summary of the status for all outstanding options at March 31, 2015, and changes during the fiscal year then ended is
presented in the table below:
Weighted
Average
Exercise Price
per Share
Weighted Average
Remaining
Contractual Life
(Years)
Aggregate
Intrinsic Value as
of March 31, 2015
Number of
Options
Options outstanding, March 31, 2014 ..............................................................................................................
1,115,984 $
Granted ...................................................................................................................................................
241,625
Exercised ................................................................................................................................................
(111,758)
Cancelled – forfeited ..............................................................................................................................
(44,854)
Cancelled – expired ................................................................................................................................
(37,818)
24.80
37.64
17.27
37.78
26.20
Options outstanding, March 31, 2015 ..............................................................................................................
1,163,179 $
3.42 $
27.65
9,894,029
Options vested and expected to vest ................................................................................................................
1,046,818 $
3.33 $
26.70
9,750,025
Ending exercisable ...........................................................................................................................................
559,168 $
2.78 $
21.20
7,636,110
The weighted average fair value of options granted during fiscal 2013, 2014, and 2015 was $9.30, $13.96, and $15.00,
respectively. The total intrinsic value of options exercised during fiscal years 2013, 2014, and 2015 were $6,776,000,
$7,726,000, and $2,455,000 respectively.
Included in the above-noted stock option grants and stock compensation expense are performance-based stock options
pursuant to which vesting occurs only upon the Company achieving certain earnings per share targets as determined by the
Company’s board of directors. The options were valued in the same manner as the time-vesting options. However, the
Company only recognizes stock compensation to the extent that the targets are probable which allow the performance options
to vest. During fiscal years ended March 31, 2013, 2014, and 2015, the Company recognized stock compensation expense for
performance-based options in the amount of ($82,000), $630,000, and $211,000, respectively.
The Company received $3,399,000, $3,386,000, and $1,603,000 of cash receipts from the exercise of stock options
during fiscal 2013, 2014, and 2015, respectively. As of March 31, 2015, $4,820,000 of total unrecognized compensation
costs related to stock options is expected to be recognized over a weighted average period of 3 years.
52
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note C — Property and Equipment
Property and equipment, net consisted of the following at March 31, 2014 and 2015:
2014
2015
Computer software ...........................................................................................................................................
Office equipment and computers .....................................................................................................................
Leasehold improvements .................................................................................................................................
$ 101,955,000
64,462,000
8,594,000
$ 90,887,000
64,525,000
5,134,000
Less: accumulated depreciation and amortization ............................................................................................
160,546,000
(109,293,000)
175,011,000
(118,712,000)
$ 51,253,000
$ 56,299,000
Depreciation expense totaled $15,941,000 and $17,537,000 for the fiscal years ended March 31, 2014 and
2015, respectively.
Note D — Accounts and Taxes Payable and Accrued Liabilities
Accounts and income taxes payable consisted of the following at March 31, 2014 and 2015:
2014
2015
Accounts payable .............................................................................................................................................
Income taxes payable .......................................................................................................................................
$13,578,000
2,192,000
$17,437,000
1,028,000
Accrued liabilities consisted of the following at March 31, 2014 and 2015:
2014
2015
$18,465,000
$15,770,000
Payroll, payroll taxes and employee benefits ...................................................................................................
Customer deposits ............................................................................................................................................
Accrued professional service fees ....................................................................................................................
Self-insurance accruals ....................................................................................................................................
Deferred revenue ..............................................................................................................................................
Accrued rent .....................................................................................................................................................
Other ................................................................................................................................................................
$17,774,000
17,760,000
5,308,000
3,305,000
7,294,000
5,608,000
1,269,000
$18,010,000
16,629,000
6,419,000
3,190,000
5,176,000
2,493,000
1,458,000
$53,375,000
$58,318,000
Note E — Income Taxes
The income tax provision consisted of the following for the three fiscal years ended March 31, 2013, 2014 and 2015:
2013
2014
2015
Current – Federal .............................................................................................................................................
Current – State .................................................................................................................................................
$ 16,534,000
136,000
$ 11,236,000
3,653,000
$ 21,978,000
2,656,000
Subtotal ............................................................................................................................................................
16,670,000
14,889,000
24,634,000
Deferred – Federal ...........................................................................................................................................
Deferred – State ...............................................................................................................................................
2,310,000
(34,000)
(2,367,000)
(152,000)
312,000
(8,000)
Subtotal ............................................................................................................................................................
(2,519,000)
2,276,000
304,000
$ 17,165,000
$ 22,115,000
$ 16,974,000
53
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note E — Income Taxes (continued)
The following is a reconciliation of the income tax provision from the statutory federal income tax rate to the effective
rate for the three fiscal years ended March 31, 2013, 2014 and 2015:
Income taxes at federal statutory
2013
2014
2015
rate (35%) ....................................................................................................................................................
State income taxes, net of federal benefit ........................................................................................................
Uncertain tax positions ....................................................................................................................................
Adjustments to returns as filed .........................................................................................................................
Other ................................................................................................................................................................
$15,947,000
1,535,000
1,346,000
(1,978,000)
124,000
$15,363,000
1,172,000
26,000
821,000
(217,000)
$20,633,000
1,826,000
(245,000)
(293,000)
194,000
$17,165,000
$22,115,000
$16,974,000
Income taxes paid totaled $9,663,000, $20,791,000, and $19,528,000 for the fiscal years ended March 31, 2013, 2014,
and 2015, respectively.
Deferred tax assets and liabilities at March 31, 2014 and 2015 are:
2014
2015
Deferred income tax assets:
Accrued liabilities not currently deductible .....................................................................................................
Allowance for doubtful accounts .....................................................................................................................
Stock-based compensation ...............................................................................................................................
Accrued rent .....................................................................................................................................................
Other ................................................................................................................................................................
$ 7,547,000
631,000
1,044,000
2,152,000
830,000
$ 6,672,000
692,000
717,000
1,267,000
955,000
Deferred assets .................................................................................................................................................
12,204,000
10,303,000
Deferred income tax liabilities:
Excess of book over tax basis of fixed assets ...................................................................................................
Intangible assets ...............................................................................................................................................
Other ................................................................................................................................................................
(15,985,000)
(5,217,000)
(564,000)
(14,409,000)
(4,934,000)
(218,000)
Deferred liabilities ............................................................................................................................................
(21,766,000)
(19,561,000)
Net deferred tax asset/(liability) .......................................................................................................................
$ (9,562,000)
$ (9,258,000)
Prepaid expenses and taxes include $1,346,000 and $5,758,000 at March 31, 2014 and 2015, respectively, for income
taxes due in the first quarter of the succeeding fiscal year.
A reconciliation of the financial statement recognition and measurement of unrecognized tax positions during the
current fiscal year is as follows:
Balance as of March 31, 2014 .........................................................................................................................
Additions based on tax positions related to the current year ...........................................................................
Additions for tax positions of prior years ........................................................................................................
Reductions for tax positions related to the current year ...................................................................................
Reductions for tax positions of prior years ......................................................................................................
$ 700,000
1,499,000
—
(60,000)
(150,000)
Balance as of March 31, 2015 .........................................................................................................................
$1,989,000
54
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note E — Income Taxes (continued)
The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. During the
years ended March 31, 2013, 2014 and 2015, the Company recognized approximately $80,000, ($173,000) and $57,000 in
interest and penalties, respectively. As of March 31, 2013, 2014 and 2015, accrued interest and penalties related to uncertain
tax positions were $257,000, $83,000 and $140,000, respectively. The Company believes there will be a material reduction in
its unrecognized tax benefits within the next 12 months as a result of amended state filings for which an estimate cannot
be made.
The tax fiscal years 2011-2014 remain open to examination by the major taxing jurisdictions to which the Company
is subject.
Note F — Employee Stock Purchase Plan
The Company maintains an Employee Stock Purchase Plan (“ESPP”) which allows employees of the Company and its
subsidiaries to purchase shares of common stock on the last day of two six-month purchase periods (i.e. March 31 and
September 30) at a purchase price which is 95% of the closing sale price of shares as quoted on NASDAQ on the last day of
such purchase period. Employees are allowed to contribute up to 20% of their gross pay. A maximum of 2,850,000 shares has
been authorized for issuance under the ESPP, as amended. As of March 31, 2015, 2,439,296 had been issued pursuant to the
ESPP. Summarized ESPP information is as follows:
2013
2014
2015
Employee contributions ...................................................................................................................................
Shares acquired ................................................................................................................................................
Average purchase price ....................................................................................................................................
$400,000
12,299
$ 32.52
$313,000
14,056
$ 22.30
$346,000
8,489
$ 40.71
Note G — Treasury Stock
During each of the fiscal years in the three fiscal year period ended March 31, 2015, the Company continued to
repurchase shares of its common stock under a plan originally approved by the Company’s Board of Directors in 1996.
Including a 2,000,000 share expansion authorized in August 2013, the total number of shares authorized to be repurchased
over the life of the plan is 34,000,000 shares. Purchases may be made from time to time depending on market conditions and
other relevant factors. The share repurchases for fiscal years ended March 31, 2013, 2014 and 2015 and cumulatively since
inception of the authorization are as follows:
2013
2014
2015
Cumulative
Shares repurchased ...........................................................................................................................................
Cost ..................................................................................................................................................................
Average price ...................................................................................................................................................
830,460
$ 27,179,000
32.73
$
1,410,812
$ 30,727,000
21.78
$
845,014
$ 31,798,000
37.63
$
32,992,488
$ 360,278,000
10.92
$
During the period subsequent to March 31, 2015, the Company repurchased 182,113 shares for $6.5 million or an
average of $35.89 per share. The repurchased shares were recorded as treasury stock, at cost, and are available for general
corporate purposes. The repurchases were primarily financed from cash generated from operations and from the cash
proceeds from the exercise of stock options.
Note H — Commitments
The Company leases office facilities under non-cancelable operating leases. Some of these leases contain escalation
clauses. Future minimum rental commitments under operating leases at March 31, 2015 are $15,324,000 in fiscal 2016,
$12,906,000 in fiscal 2017, $9,554,000 in fiscal 2018, $5,398,000 in fiscal 2019, $3,212,000 in fiscal 2020, $5,136,000
thereafter, and $51,530,000 in the aggregate. Total rental expense of $13,951,000, $13,890,000, and $15,297,000 was
charged to operations for the fiscal years ended March 31, 2013, 2014, and 2015, respectively.
55
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note I — Contingencies and Legal Proceedings
The Company is involved in litigation arising in the normal course of business. Management believes that resolution of these
matters will not result in any payment that, in the aggregate, would be material to the financial position or results of the
operations of the Company.
Note J — Retirement Savings Plan
The Company maintains a retirement savings plan for its employees, which is a qualified plan under Section 401(k) of
the Internal Revenue Code. Full-time employees that meet certain requirements are eligible to participate in the plan.
Employer contributions are made annually, primarily at the discretion of the Company’s Board of Directors. Contributions of
$372,000, $338,000 and $443,000 were charged to operations for the fiscal years ended March 31, 2013, 2014, and
2015, respectively.
Note K — Shareholder Rights Plan
During fiscal 1997, the Company’s Board of Directors approved the adoption of a Shareholder Rights Plan. The
Shareholder Rights Plan provides for a dividend distribution to CorVel stockholders of one preferred stock purchase right for
each outstanding share of CorVel’s common stock under certain circumstances. In April 2002, the Board of Directors of
CorVel approved an amendment to the Shareholder Rights Plan to extend the expiration date of the rights to February 10,
2012, set the exercise price of each right at $118, and enable Fidelity Management & Research Company and its affiliates to
purchase up to 18% of the shares of common stock of the Company without triggering the stockholder rights, with the
limitations under the Shareholder Rights Plan remaining in effect for all other stockholders of the Company. In November
2008, the Company’s Board of Directors approved an amendment to the Shareholder Rights Plan to extend the expiration
date of the rights to February 10, 2022, remove the ability of Fidelity Management & Research Company and its affiliates to
purchase up to 18% of the shares of common stock of the Company without triggering the stockholder rights, substitute
Computershare Trust Company, N.A. as the rights agent and effect certain technical changes to the Shareholder Rights Plan.
Generally, the Shareholder Rights Plan provides that if a person or group acquires 15% or more of the Company’s
common stock without the approval of the Board, subject to certain exceptions, the holders of the rights, other than the
acquiring person or group, would, under certain circumstances, have the right to purchase additional shares of the Company’s
common stock having a market value equal to two times the then-current exercise price of the right. In addition, if the
Company is thereafter merged into another entity, or if 50% or more of the Company’s consolidated assets or earning power
are sold, then the right will entitle its holder to buy common shares of the acquiring entity having a market value equal to two
times the then-current exercise price of the right. The Company’s Board of Directors may exchange or redeem the rights
under certain conditions.
Note L — Line of Credit
In September 2014, the Company renewed a line of credit agreement. The line is with a financial institution to provide
a revolving credit facility with borrowing capacity of up to $10 million. Borrowings under this agreement bear interest, at the
Company’s option, at a fixed LIBOR-based rate plus 1.50% or at a fluctuating rate determined by the financial institution to
be 1.50% above the daily one-month LIBOR rate. The loan covenants require the Company to maintain the current assets to
liabilities ratio of at least 1.25:1, debt to tangible net worth not greater than 1.25:1 and have positive net income. The
Company’s management believes it was in compliance with all of its loan covenants as of March 31, 2015. As of March 31,
2015, the Company had borrowed on the line of credit in the amount of $618,000, which was included in accrued liabilities
on the balance sheet and was paid off on April 1, 2015. Letters of credit in the aggregate amount of $4.5 million have been
issued separate from the line of credit and therefore do not reduce the amount of borrowings available under the revolving
credit facility. The renewed credit agreement expires in September 2015.
56
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note M — Quarterly Results (Unaudited)
The following is a summary of unaudited quarterly results of operations for each of the quarters in the two fiscal years
ended March 31, 2014 and 2015:
Revenues
Gross Profit
Net Income
Net Income
per Basic
Common
Share
Net Income
per Diluted
Common
Share
Fiscal Year Ended March 31, 2014:
First Quarter .....................................................................................................................................................
Second Quarter ................................................................................................................................................
Third Quarter ...................................................................................................................................................
Fourth Quarter .................................................................................................................................................
Fiscal Year Ended March 31, 2015:
First Quarter .....................................................................................................................................................
Second Quarter ................................................................................................................................................
Third Quarter ...................................................................................................................................................
Fourth Quarter .................................................................................................................................................
$8,609,000 $
8,675,000
8,775,000
8,333,000
$8,299,000 $
7,883,000
6,832,000
5,576,000
$124,364,000
123,714,000
122,352,000
122,195,000
$118,113,000
119,359,000
121,098,000
120,246,000
$27,700,000
25,467,000
24,128,000
22,674,000
$26,918,000
27,320,000
27,706,000
26,537,000
0.40 $
0.41
0.42
0.40
0.40 $
0.38
0.33
0.27
0.40
0.41
0.41
0.39
0.39
0.37
0.33
0.27
Note N — Segment Reporting
The Company derives the majority of its revenues from providing patient management and network solutions services
to payors of workers’ compensation benefits, automobile insurance claims and health insurance benefits. Patient management
services include claims administration, utilization review, medical case management, and vocational rehabilitation. Network
solutions revenues include fee schedule auditing, hospital bill auditing, coordination of independent medical examinations,
diagnostic imaging review services and preferred provider referral services. The percentages of revenues attributable to
patient management and network solutions services for the fiscal years ended March 31, 2013, 2014, and 2015 are
listed below.
2013
2014
2015
Patient management services ............................................................................................................................
Network solutions services ...............................................................................................................................
54.5%
45.5%
51.5%
48.5%
51.9%
48.1%
100.0%
100.0%
100.0%
The Company’s management is structured geographically with regional vice-presidents who report to the Chief
Executive Officer of the Company. Each of these regional vice-presidents is responsible for all services provided by the
Company in his or her particular region and responsible for the operating results of the Company in multiple states. These
regional vice-presidents have area and district managers who are also responsible for all services provided by the Company in
their given area and district.
Under FASB ASC 280-10, two or more operating segments may be aggregated into a single operating segment for
financial reporting purposes if aggregation is consistent with the objective and basic principles, if the segments have similar
economic characteristics, and if the segments are similar in each of the following areas: 1) the nature of products and
services; 2) the nature of the production processes; 3) the type or class of customer for their products and services; and 4) the
methods used to distribute their products or provide their services. The Company believes each of the Company’s regions
meet these criteria as they provide similar managed care services to similar customers using similar methods of productions
and similar methods to distribute their services. All of the Company’s regions perform both patient management and network
solutions services.
Because the Company believes it meets each of the criteria set forth above and each of the Company’s regions has
similar economic characteristics, the Company aggregates its results of operations in one reportable operating segment.
57
CORVEL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fiscal Years Ended March 31, 2013, 2014 and 2015
Note O — Other Intangible Assets
Other intangible assets consist of the following at March 31, 2014:
Item
Covenant Not to Compete............................................ 5 years
Customer relationships ................................................
TPA Licenses ...............................................................
18-20 years
15 years
Life
Cost
$ 775,000
7,922,000
204,000
Fiscal 2014
Amortization
Expense
$ 34,000
422,000
14,000
Accumulated
Amortization at
March 31, 2014
742,000
$
2,876,000
90,000
Cost, Net of
Accumulated
Amortization at
March 31, 2014
33,000
$
5,046,000
114,000
Total .............................................................................
$ 8,901,000
$ 470,000
$ 3,708,000
$ 5,193,000
Other intangible assets consist of the following at March 31, 2015:
Item
Covenant Not to Compete............................................
Customer Relationships ...............................................
TPA Licenses ...............................................................
5 years
18-20 years
15 years
Life
Cost
$ 775,000
7,922,000
204,000
Fiscal 2015
Amortization
Expense
$ 20,000
423,000
14,000
Accumulated
Amortization at
March 31, 2015
762,000
$
3,299,000
104,000
Cost, Net of
Accumulated
Amortization at
March 31, 2015
13,000
$
4,623,000
100,000
Total .............................................................................
$ 8,901,000
$ 457,000
$ 4,165,000
$ 4,736,000
Amortization expense for the next five fiscal years is expected to be $449,000 in fiscal 2016, $437,000 in fiscal 2017,
$437,000 in fiscal 2018, $437,000 in fiscal 2019, $437,000 in fiscal 2020, and $2,539,000 thereafter.
58
Exhibit
No.
3.1
3.2
10.1*
10.2*
10.3*
10.4*
10.5*
10.6*
10.7*
10.8
10.9
10.10
10.11
10.12
EXHIBIT INDEX
Title — Method of Filing
Amended and Restated Certificate of Incorporation of the Company — Incorporated herein by reference to
Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on August 10, 2011.
Amended and Restated Bylaws of the Company — Incorporated herein by reference to Exhibit 3.2 to the
Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2006 filed on August 14,
2006.
Nonqualified Stock Option Agreement between V. Gordon Clemons, Sr., the Company and North Star together
with all amendments and addendums thereto — Incorporated herein by reference to Exhibit 10.6 to the
Company’s Registration Statement on Form S-1 Registration No. 33-40629 initially filed on May 16, 1991.
Supplementary Agreement between V. Gordon Clemons, Sr., the Company and North Star — Incorporated
herein by reference to Exhibit 10.7 to the Company’s Registration Statement on Form S-1 Registration
No. 33-40629 initially filed on May 16, 1991.
Amendment to Supplementary Agreement between V. Gordon Clemons, Sr., the Company and North Star —
Incorporated herein by reference to Exhibit 10.5 to the Company’s Annual Report on Form 10-K for the fiscal
year ended March 31, 1992 filed on June 29, 1992.
Restated Omnibus Incentive Plan (Formerly The Restated 1988 Executive Stock Option Plan) — Incorporated
herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 10, 2011.
Forms of Notice of Grant of Stock Option, Stock Option Agreement and Notice of Exercise Under the Restated
Omnibus Incentive Plan (Formerly The Restated 1988 Executive Stock Option) — Incorporated herein by
reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended
September 30, 2006 filed on November 9, 2006, Exhibits 10.7, 10.8 and 10.9 to the Company’s Annual Report
on Form 10-K for the fiscal year ended March 31, 1994 filed on June 29, 1994, Exhibits 99.2, 99.3, 99.4, 99.5,
99.6, 99.7 and 99.8 to the Company’s Registration Statement on Form S-8 (File No. 333-94440) filed on
July 10, 1995, and Exhibits 99.3 and 99.5 to the Company’s Registration Statement on Form S-8
(File No. 333-58455) filed on July 2, 1998.
Employment Agreement of V. Gordon Clemons, Sr. — Incorporated herein by reference to Exhibit 10.12 to the
Company’s Registration Statement on Form S-1 Registration No. 33-40629 initially filed on May 16, 1991.
Restated 1991 Employee Stock Purchase Plan, as amended — Incorporated herein by reference to Exhibit 10.1
to the Company’s Current Report on Form 8-K/A filed on August 12, 2010.
Fidelity Master Plan for Savings and Investment, and amendments — Incorporated herein by reference to
Exhibits 10.16 and 10.16A to the Company’s Registration Statement on Form S-1 Registration No. 33-40629
initially filed on May 16, 1991.
Second Amended and Restated Preferred Shares Rights Agreement, dated as of November 17, 2008, by and
between CorVel Corporation and Computershare Trust Company, N.A., including the original Certificate of
Designation, the Certificate of Designation Increasing the Number of Shares, the form of Right Certificate (as
amended) and the Summary of Rights (as amended) attached thereto as Exhibits A-1, A-2, A-3, B and C,
respectively. Incorporated herein by reference to Exhibit 4.1 to the Company’s Form 8-K filed on November
24, 2008.
Credit Agreement dated May 28, 2009 by and between CorVel Corporation and Wells Fargo Bank, National
Association. — Incorporated herein by reference to Exhibit 10.16 to the Company’s Current Report on
Form 8-K filed on June 4, 2009.
Revolving Line of Credit Note dated May 28, 2009 by CorVel Corporation in favor of Wells Fargo Bank,
National Association. — Incorporated herein by reference to Exhibit 10.17 to the Company’s Current Report on
Form 8-K filed on June 4, 2009.
Form of Partial Waiver of Automatic Option Grant executed by Directors — Incorporated herein by reference
to Exhibit 10.18 to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September
30, 2007 filed on November 8, 2007.
59
Exhibit
No.
10.13
10.14
10.15
10.16*
10.17
10.18
EXHIBIT INDEX (continued)
Title — Method of Filing
Partial Waiver of Automatic Option Grant by Jean H. Macino dated February 8, 2008 — Incorporated herein by
reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31,
2008 filed on June 16, 2008.
First Amendment to Credit Agreement dated June 2, 2010 by and between CorVel Corporation and Wells
Fargo Bank, National Association. Incorporated herein by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K filed on June 7, 2010.
Revolving Line of Credit Note dated June 2, 2010 by CorVel Corporation in favor of Wells Fargo Bank,
National Association. Incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on
Form 8-K filed on June 7, 2010.
Stock Option Agreement dated December 6, 2010 between the company and Diane J. Blaha, providing
performance vesting. Inocorpated herein by reference to Exhibit 10.32 to the Company’s Annual Report on
Form 10-K for the fiscal year ended March 31, 2014 filed on June 12, 2014.
Second Amendment to Credit Agreement dated September 1, 2011 by and between CorVel Corporation and
Wells Fargo Bank, National Association. Incorporated herein by reference to Exhibit 10.1 to the Company’s
Current Report on Form 8-K filed on August 31, 2011.
Revolving Line of Credit Note dated September 1, 2011 by CorVel Corporation in favor of Wells Fargo Bank,
National Association. Incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on
Form 8-K filed on August 31, 2011.
10.19*†
Stock option agreement dated November 3, 2011 between the Company and Diane J. Blaha, providing
performance vesting. Refiled herewith.
10.20
10.21
10.22*†
10.23*†
10.24*†
10.25*†
10.26
10.27
10.28*†
10.29*†
10.30*†
Third Amendment to Credit Agreement dated September 1, 2012 by and between CorVel Corporation and
Wells Fargo Bank, National Association. Incorporated herein by reference to Exhibit 10.1 to the Company’s
Current Report on Form 8-K filed on September 7, 2012.
Revolving Line of Credit Note dated September 1, 2012 by CorVel Corporation in favor of Wells Fargo Bank,
National Association. Incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on
Form 8-K filed on September 7, 2012.
Stock option agreement dated March 1, 2013 between the Company and V. Gordon Clemons, Sr., providing
performance vesting. Refiled herewith.
Stock option agreement dated March 1, 2013 between the Company and Scott McCloud, providing
performance vesting. Refiled herewith.
Stock option agreement dated March 1, 2013 between the Company and Donald C. McFarlane, providing
performance vesting. Refiled herewith.
Stock option agreement dated March 1, 2013 between the Company and Diane J. Blaha, providing performance
vesting. Refiled herewith.
Fourth Amendment to Credit Agreement dated September 1, 2013 by and between CorVel Corporation and
Wells Fargo Bank, National Association. Incorporated herein by reference to Exhibit 10.1 to the Company’s
Current Report on Form 8-K filed on September 5, 2013.
Revolving Line of Credit Note dated September 1, 2013 by CorVel Corporation in favor of Wells Fargo Bank,
National Association. Incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on
Form 8-K filed on September 5, 2013.
Stock option agreement dated November 4, 2013 between the Company and Scott McCloud, providing
performance vesting. Refiled herewith.
Stock option agreement dated November 4, 2013 between the Company and Donald C. McFarlane, providing
performance vesting. Refiled herewith.
Stock option agreement dated November 4, 2013 between the Company and Diane J. Blaha, providing
performance vesting. Refiled herewith.
60
EXHIBIT INDEX (continued)
Exhibit
No.
10.31*†
10.32*†
10.33
10.34
10.35*†
10.36*†
21.1
23.1
31.1
31.2
32.1
32.2
101.0
Title — Method of Filing
Stock option agreement dated November 4, 2013, between the Company and Richard Schweppe, providing
performance vesting. Refiled herewith.
Stock option agreement dated March 1, 2013, between the Company and Richard Schweppe, providing
performance vesting. Refiled herewith.
Fifth Amendment to Credit Agreement dated September 1, 2014 by and between CorVel Corporation and
Wells Fargo Bank, National Association. Incorporated herein by reference to Exhibit 10.1 to the Company’s
Current Report on Form 8-K filed on September 5, 2014.
Revolving Line of Credit Note dated September 1, 2014 by CorVel Corporation in favor of Wells Fargo Bank,
National Association. Incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on
Form 8-K filed on September 5, 2014.
Stock option agreement dated November 19, 2014, between the Company and Richard Schweppe, providing
performance vesting. Incorporated herein by reference to Exhibit 10.1 to the Company’s Quarterly Report on
Form 10-Q for the quarterly period ended December 31, 2014 filed on February 5, 2015.
Stock option agreement dated November 19, 2014, between the Company and Diane J. Blaha, providing
performance vesting. Incorporated herein by reference to Exhibit 10.2 to the Company’s Quarterly Report on
Form 10-Q for the quarterly period ended December 31, 2014 filed on February 5, 2015.
Subsidiaries of the Company. Filed herewith.
Consent of Independent Registered Public Accounting Firm, Haskell & White LLP. Filed herewith.
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. —
Filed herewith.
Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. —
Filed herewith.
Certification of the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002. — Furnished herewith.
Certification of the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section
906 of the Sarbanes-Oxley Act of 2002. — Furnished herewith.
The following materials from CorVel Corporation’s Annual Report on Form 10-K for the fiscal year ended
March 31, 2015, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance
Sheets as of March 31, 2015 and March 31, 2014; (ii) Consolidated Statements of Income for the fiscal years
ended March 31, 2015, 2014 and 2013; (iii) Consolidated Statements of Stockholders’ Equity for the fiscal
years ended March 31, 2015, 2014 and 2013; (iv) Consolidated Statements of Cash Flows for the fiscal years
ended March 31, 2015, 2014 and 2013; and (v) Notes to Consolidated Financial Statements.
* — Denotes management contract or compensatory plan or arrangement.
† — Confidential treatment has been requested for certain confidential portions of this exhibit pursuant to Rule 24b-2
under the Securities Exchange Act of 1934. In accordance with Rule 24b-2, these confidential portions have been
omitted from this exhibit and filed separately with the Securities and Exchange Commission.
61
EXHIBIT 21.1 — SUBSIDIARIES OF THE REGISTRANT
Name of Subsidiary
State of Incorporation
Relationship to Registrant
CorVel Health Care Organization
CorVel Healthcare Corporation
California
California
CorVel Enterprise Comp, Inc. of New York
New York
CorVel Enterprise Comp, Inc.
CorVel IME Corporation
CareIQ, Inc.
Enterprise Comp, Inc.
CorVel Ohio MCO, Inc.
Eagle Claims Services, Inc.
CorVel NY IPA, Inc.
CorVel Rehabilitation Services, Inc.
Delaware
New York
Minnesota
Delaware
Ohio
New York
New York
Minnesota
wholly-owned subsidiary
wholly-owned subsidiary
wholly-owned subsidiary
wholly-owned subsidiary
wholly-owned subsidiary
wholly-owned subsidiary
wholly-owned subsidiary
wholly-owned subsidiary
wholly-owned subsidiary
wholly-owned subsidiary
wholly-owned subsidiary
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-144402, 333-58455,
333-16379, 333-107428, 333-128739, 333-94440, 333-53684, 333-48186, 333-42554, and 333-42424) of CorVel
Corporation (the “Company”) of our report dated June 11, 2015, relating to the Company’s consolidated financial statements,
financial statement schedule and internal controls included in the Company’s Annual Report on Form 10-K for the fiscal year
ended March 31, 2015.
HASKELL & WHITE LLP
EXHIBIT 23.1
Irvine, California
June 11, 2015
Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, V. Gordon Clemons, Sr., certify that:
1. I have reviewed this annual report on Form 10-K of CorVel Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were made,
not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons
performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant’s internal control over financial reporting.
Date: June 11, 2015
/s/ V. Gordon Clemons, Sr.
V. Gordon Clemons, Sr.
Chairman of the Board, President, Chief Executive
Officer (Principal Executive Officer)
Exhibit 31.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Richard J. Schweppe, certify that:
1. I have reviewed this annual report on Form 10-K of CorVel Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were made,
not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred
during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons
performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant’s internal control over financial reporting.
Date: June 11, 2015
/s/ Richard J. Schweppe
Richard J. Schweppe
Chief Financial Officer (Principal Financial
and Accounting Officer)
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Exhibit 32.1
In connection with the Annual Report of CorVel Corporation (the “Registrant”) on Form 10-K for the fiscal year ended
March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Annual Report”), I, V.
Gordon Clemons, Sr., Chief Executive Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) the Annual Report fully complies with the requirements of Section 13(a) or 15 (d) of the Securities Exchange Act of
1934; and
(2) the information contained in the Annual Report fairly presents, in all material respects, the financial condition and
results of operations of the Registrant.
/s/ V. Gordon Clemons, Sr.
V. Gordon Clemons, Sr.
Chairman of the Board, President, Chief Executive Officer
(Principal Executive Officer)
June 11, 2015
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or
otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by
Section 906, has been provided to CorVel Corporation and will be retained by CorVel Corporation and furnished to the
Securities and Exchange Commission or its staff upon request.
This certification accompanies this Annual Report and is being furnished pursuant to Item 601(b)(32) of Regulation S-K
promulgated under the Securities Act of 1933, as amended (the “Securities Act”) and the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), and pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. This certification shall not,
except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Registrant for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of
that section, or incorporated by reference into any filing under the Securities Act or the Exchange Act, except as shall be
expressly set forth by specific incorporation by reference in such a filing.
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Exhibit 32.2
In connection with the Annual Report of CorVel Corporation (the “Registrant”) on Form 10-K for the fiscal year ended
March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Annual Report”), I, Richard
J. Schweppe, Chief Financial Officer of the Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) the Annual Report fully complies with the requirements of Section 13(a) or 15 (d) of the Securities Exchange Act of
1934; and
(2) the information contained in the Annual Report fairly presents, in all material respects, the financial condition and
results of operations of the Registrant.
/s/ Richard J. Schweppe
Richard J. Schweppe
Chief Financial Officer (Principal Financial and
Accounting Officer)
June 11, 2015
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or
otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by
Section 906, has been provided to CorVel Corporation and will be retained by CorVel Corporation and furnished to the
Securities and Exchange Commission or its staff upon request.
This certification accompanies this Annual Report and is being furnished pursuant to Item 601(b)(32) of Regulation S-K
promulgated under the Securities Act of 1933, as amended (the “Securities Act”) and the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), and pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. This certification shall not,
except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Registrant for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of
that section, or incorporated by reference into any filing under the Securities Act or the Exchange Act, except as shall be
expressly set forth by specific incorporation by reference in such a filing.
Revenue (in millions)
Annual Revenue Per Q4 Weighted Shares
Earnings Per Share (in dollars)
$25
20
15
10
5
$0
35%
25
15
5
0%
$500
$400
300
200
100
$0
$35
25
15
5
$0
97
99
01
03
05
07
09
11
13
15
Net Income (in millions)
97
99
01
03
05
07
09
11
13
15
Corporate Address
CorVel Corporation
2010 Main Street
Suite 600
Irvine, California 92614
Telephone: 888.7.CORVEL
Transfer Agent and Registrar
Computershare Investor Services
Canton, Massachusetts
Counsel
Dorsey & Whitney, LLP
Costa Mesa, California
$1.75
1.50
1.25
1.00
0.75
0.50
0.25
$0
97
99
01
03
05
07
09
11
13
15
97
99
01
03
05
07
09
11
13
15
Return on Equity (%)
Q4 Weighted Shares (in millions)
45
35
25
15
5
0
97
99
01
03
05
07
09
11
13
15
Investor Relations
CorVel Corporation
2010 Main Street
Suite 600
Irvine, California 92614
Telephone: 888.7.CORVEL
www.corvel.com/ar2015
investor_relations@corvel.com
97
99
01
03
05
07
09
11
13
15
Independent Auditors
Haskell & White LLP
Irvine, California
Stock Symbol
The common stock of CorVel
Corporation is traded on the
NASDAQ Global Select Market
under the stock symbol CRVL.
Form 10K
CorVel Corporation Annual Report on Form
10K filed with the Securities and Exchange
Commission may be obtained without charge
by contacting Investor Relations.
®
www.corvel.com